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ABSTRACT
Background: Inherited epidermolysis bullosa (EB) is a genetic disorder charac-
terized by skin fragility and unique oral features.
Aims: To provide (a) a complete review of the oral manifestations in those liv-
ing with each type of inherited EB, (b) the current best practices for manag-
ing oral health care of people living with EB, (c) the current best practices on
dental implant-based oral rehabilitation for patients with recessive dystrophic
EB (RDEB), and (d) the current best practice for managing local anesthesia,
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principles of sedation, and general anesthesia for children and adults with EB
undergoing dental treatment.
Methods: Systematic literature search, panel discussion including clinical
experts and patient representatives from different centers around the world,
external review, and guideline piloting.
Results: This article has been divided into five chapters: (i) general information
on EB for the oral health care professional, (ii) systematic literature review on
the oral manifestations of EB, (iii) oral health care and dental treatment for chil-
dren and adults living with EB—clinical practice guidelines, (iv) dental implants
in patients with RDEB—clinical practice guidelines, and (v) sedation and anes-
thesia for adults and children with EB undergoing dental treatment—clinical
practice guidelines.
Each chapter provides recommendations on the management of the differ-
ent clinical procedures within dental practice, highlighting the importance of
patient-clinician partnership, impact on quality of life, and the importance of
follow-up appointments. Guidance on the use on nonadhesive wound care prod-
ucts and emollients to reduce friction during patient care is provided.
Conclusions: Oral soft and hard tissue manifestations of inherited EB have
unique patterns of involvement associated with each subtype of the condition.
Understanding each subtype individually will help the professionals plan long-
term treatment approaches.
KEYWORDS
clinical practice guideline, dental implants, dental treatment, dystrophic epidermolysis bul-
losa, epidermolysis bullosa, epidermolysis bullosa simplex, general anesthesia, junctional epi-
dermolysis bullosa, kindler epidermolysis bullosa, oral care, oral rehabilitation, recessive dys-
trophic epidermolysis bullosa, sedation
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Introduction
Inherited epidermolysis bullosa (EB) is a genetic disorder
characterized by skin fragility. Affected individuals present
unique oral features, requiring a special approach from the
dental team.
The International Dystrophic Epidermolysis Bullosa
Research Association (DEBRA International) is the world-
wide network of national groups working on behalf of
those affected by EB. As part of their vision for working to
ensure access to the best quality support and medical care
for people living with EB, DEBRA International entrusts
the development of clinical practice guideline (CPG) to
health care professionals with significant experience in EB
around the world. In 2012, the first CPG on oral health
care for patients with EB was published.1 New literature
reviews, case series, and case reports have been published.
It has become necessary to update the guideline including
the new evidence, as well as including more experts from
different centers around the world.
Considering the new information and wider scope
of treatment alternatives, the present update has been
divided into five chapters: (i) general information on EB
for the oral health care professional (update), (ii) system-
atic literature review of oral manifestations of EB (update),
(iii) CPG on oral health care for children and adults liv-
ing with EB (update), (iv) dental Implants in patients with
recessive dystrophic EB (new guideline), and (v) sedation
and anesthesia for patientswithEBundergoing dental care
(update).
REFERENCE
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CHAPTER 1: General information on epidermolysis bullosa
for the oral health care professional
Susanne Krämer
Inherited epidermolysis bullosa (EB) is a group of genetic
disorders with skin fragility and blistering. Clinically, it
is highly heterogeneous, presenting blisters and erosions
not only on skin, but also on mucous membranes as well
as affecting other tissues. It is caused by variants in the
genes encoding proteins of the dermal-epidermal adhe-
sion zone.1 Acquired forms of EB, caused by autoantibod-
ies to type VII collagen, are known as Epidermolysis Bul-
losa Acquisita (EBA). This guideline will only discuss the
inherited types of EB.
1.1 Diagnosis and classification
EB presents a wide range of clinical phenotypes with thou-
sands of sequence variants identified in at least 16 struc-
tural genes.1,2 Classification schemes were first introduced
by Pearson in 1962.3 Since then various consensus classi-
fications have been published.1,4–7 The current classifica-
tion system has an “onion skin” approach. First, the major
type is diagnosed based on the level of blister formation
into: (a) EB simplex (EBS), (b) junctional EB (JEB), (c) dys-
trophic EB (DEB), and (d) Kindler EB (KEB, previously
known as Kindler syndrome). Then the subclassification
considers the clinical phenotypic features such as distri-
bution (localized vs generalized), relative severity of cuta-
neous and extracutaneous involvement, mode of transmis-
sion, and specific gene involved. The 2020 classification
system recognizes four major types, 35 subtypes, and five
other disorders with skin fragility.1 The latest consensus
reclassification published in February 2020 introduces the
concept of genetic disorders with skin fragility and sepa-
rates a category of “EB-related” disorders.1 The main lab-
oratory test to reach a diagnosis is immunofluorescence
mapping (IFM) and genetic testing,8 helping to identify the
protein that is altered or missing and the gene affected.
Dentists, as part of the multidisciplinary team, need to
know and understand the complexity of the patient’s diag-
nosis, in order to understand the prognosis and plan the
treatment.When reporting a case in the literature, diagnos-
tic information including EB type, subtype, and method
used to obtain the diagnosis should be reported whenever
available.
TABLE 1 . 1 List of abbreviations
EB Epidermolysis Bullosa
EBS EB Simplex
JEB Junctional EB
DEB Dystrophic EB
RDEB Recessive DEB
DDEB Dominant DEB
Sev RDEB Severe RDEB
KEB Kindler EB
DEBRA Dystrophic Epidermolysis Bullosa Research
Association
DI DEBRA International
CPG Clinical practice guideline
SCC Squamous cell carcinoma
OSSC Oral squamous cell carcinoma
IFM Immunofluorescence mapping
1.2 Epidemiology
The estimated incidence of inherited EB is 19.6 per 1 mil-
lion live births (about 1:50.000) and the prevalence is 11
cases per million inhabitants.9 Each type and subtype of
EB has a different prognosis. Fine and coworkers analyzed
the cumulative risk of death of children with EB.10 Impor-
tant difference can be observed among types and subtypes.
While no deaths occurred during the first 15 years of life in
patients with localized EBS and dominant dystrophic EB
(DDEB), the cumulative risk of death at the age of 1 was
2.8% in severe EBS and 40% in JEB. By the age of 15, the
cumulative risk of death was 62% in severe JEB and 8% in
severe recessive dystrophic EB (RDEB). The main causes
are sepsis, failure to thrive, and respiratory failure.10 In
adults, themain causes of death are cardiomyopathy, renal
failure, and squamous cell carcinoma (SCC).11 SCC is the
leading cause of death in patients with RDEB,12 particu-
larly the severe form of RDEB with a cumulative risks of
death from SCC of 38.7%, 70.0%, and 78.7% by ages 35, 45,
and 55, respectively.13
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1.3 General clinical manifestations
The hallmark feature of inherited EB is mechanical
fragility of the skin and the appearance of blisters and bul-
lae (Image 1.1). In most forms of EB, tense blisters form
with clear, colorless exudate or occasionally hemorrhagic
fluid, eventually giving rise to eroded areas.14 The blis-
ters and erosions can occur as a result of trauma but may
also arise spontaneously and can be exacerbated by sweat-
ing and warmer climates.15 Other findings include milia,
dystrophy or absence of nails, alopecia, exuberant gran-
ulation tissue, congenital absence of skin, palmoplantar
keratoderma,mottled pigmentation, and pigmented naevi.
Secondary skin lesions are cutaneous atrophy, scarring,
pigmentary abnormalities, webbing, and contractures that
can each arise secondary to the vesiculobullous and erosive
lesions.14
SCC of the skin is one of the most severe complica-
tions of EB, starting to arise in early adulthood in patients
with the severe forms of EB, particularly severe general-
ized recessive dystrophic EB (RDEB sev-gen) (Image 1.2).
SCC can present as (a) a nonhealing wound; (b) a rapidly
growing wound, especially one that is heaped up, resem-
bling exuberant granulation tissue; (c) a deep, punched-
out ulcer, especially if it has a raised or rolled edge; (d) an
area of hyperkeratosis, especially if surrounded by a shoul-
der of raised skin; and (e) a wound with altered sensation
relative to normal EB wounds (eg, tingling or increased
pain).12
IMAGE 1 . 1 Extensive bullae covering the back of a patientwith
RDEB
IMAGE 1 . 2 Squamous cell carcinoma in RDEB
IMAGE 1 . 3 Severe esophageal stenosis in a patient with RDEB
1.3.1 Eyes, ears, nose, and throat
Ocular findings include corneal blisters and erosions,
corneal scarring, pannus formation, limbal broadening,
conjunctival blisters, erosions, symblepharon, eyelid blis-
ters and scars, ectropion, and lacrimal duct obstruction.
Marked visual impairment can result from repeated injury
to the cornea, especially if scarring develops. Signs and
symptoms in the upper respiratory tract can include weak
or hoarse cry, dysphonia, inspiratory stridor, soft tissue
edema, vesiculation or blistering of all tracheolaryngeal
structures and ulceration, thickening, and scarring of the
true and false vocal cords.14
1.3.2 Gastrointestinal complications
EB-associated esophageal strictures in the proximal area
may arise, resulting in progressive dysphagia and requir-
ing esophageal balloon dilatations (Image 1.3).16 This has
an impact on dental care. Prescriptions need to consider
the patient’s ability to swallow. A prescription in liquid
form should be considered.17 The most common lower
gastrointestinal complaint in severe EB types is chronic
constipation.14
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IMAGE 1 . 4 Mitten deformities in RDEB
1.3.3 Acral deformities
Pseudosyndactyly is the most visible extracutaneous com-
plication of inherited EB and is primarily seen in RDEB
(Image 1.4). These progressive deformities can cause
marked functional disability.14 These also have an impact
on dental care, as ability to brush the teeth independently
may be affected.17 Guidance on occupational therapy in EB
can be found in the recently published CPG.18
1.3.4 Other complications
Nutritional compromise is proportional to the severity
of EB and occurs mainly in generalized form of RDEB
and JEB.19,20 Patients can also present anemia,14 dilated
cardiomyopathy,21 osteoporosis, and osteopenia.22
1.4 Clinical care
DEBRA International has supported and funded the
development of CPG in skin and wound care,23,24 pain
management,25 psychosocial care,26 foot care,27 as well
as the guidelines that have already been cited in this
article.8,12,17,18 Research is also supported to explore gene,
protein, and cell therapies. Updated information is contin-
uously provided through the Charities web page.28
1.5 Quality of life in EB
In complex conditions, such as EB, understanding the bur-
den in patient’s quality of life is important. The main areas
where individual with EB have described concerns include
(a) having an itchy skin, (b) being in pain, (c) having diffi-
culties with participation/joining others, (d) the visibility
of the disease, and (e) the feeling of being different.29 A
quality of life questionnaire specific for patients with EB
(QOLEB) was developed by Frew, Murrell, and coworkers.
The questionnaire contains 17 items and has proven to be
a valid and reliable measurement tool. It can be used to
monitor quality of life and to identify dimensions of QOL
as targets for interventions and research.30
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CHAPTER 2: Oral manifestations of epidermolysis bullosa:
Systematic literature review
Susanne Krämer | Francisca Gamboa | Ignacio Araya | Fernanda Castrillón | Camila
Paredes | Fatimah Alsayer | Victoria Clark
Introduction
Children and adults living with inherited epidermolysis
bullosa (EB) present unique oral features related to their
specific EB type and subtype. These arise as a consequence
of the functional abnormality of the proteins in their base-
ment membrane. The Oral Health Care for Patients with
Epidermolysis Bullosa - Best Clinical Practice Guidelines1
published in 2012 included a review of the literature on
the oral characteristics of the condition. A new systematic
literature review became necessary, as new reviews, case
series, and case reports have been published.
Aim
The aim of this chapter is to provide a complete revision of
the wide spectrum of oral manifestations present in people
diagnosed with inherited EB. As such, this article consid-
ers information for all four major types of EB: EB Simplex,
Junctional EB, Dystrophic EB, and Kindler EB.
Methods
Eligibility criteria
Articles in which the main topics are oral care and precau-
tions during dental treatment (diagnosis, and/or treatment
and/or prognosis) of patients with EB, published from 1947
to March 2020 in any language.
Information sources
The literature search ranged from 1947 toMarch 2020. Con-
sulted sources included the electronic databases PUBMED
(1966 to March 31, 2020), EMBASE (1947 to March 31,
2020), Cochrane Database of Systematic Reviews (1992
to March 31, 2020), and the Cochrane-controlled trials
register (CENTRAL) (1992 to March 31, 2020). Disserta-
tions, conference proceedings, technical reports, and other
unpublished documents that meet the selection criteria
were also included. The reference lists of all papers for rele-
vant citations were reviewed.When all the relevant studies
were identified, they were sent to the experts to review for
completeness.
Search strategy
To identify studies for this review, detailed search strate-
gies were developed for each database. These were based
on the search strategy developed for PUBMED and revised
appropriately for each database.
The search strategy used a combination of controlled
vocabulary and free text terms based on:
#1 "Epidermolysis Bullosa"[Mesh]
#2 ((Epidermolysis[tiab] OR Acantholysis[tiab]))
AND Bullosa[tiab]
#3 "Dentistry"[Mesh]
#4 "Oral Health"[Mesh]
#5 "Mouth Diseases"[Mesh]
#6 "Dentistry"[tiab]
#7 #1 OR #2
#8 #3 OR #4 OR #5 OR #6
#9 #7 AND #8
Study selection
Articles that included detailed information on the patient’s
EB diagnosis and description of oral features were consid-
ered, including case reports and case series. It was desir-
able for the reports to have the EB diagnoses confirmed by
IFM or genetic testing; however, this was largely unavail-
able and could not be used as a selection criterion. The cri-
teria used to reject articles at first-stage screening (based
on title and abstract) and second-stage screening (based
on a review of the full text) were: (a) The article does
not relate to inherited EB. (b) The article describes inher-
ited EB, but does not consider oral aspects. (c) The arti-
cle describes inherited EB and oral aspects, but only den-
tal treatment is detailed, without describing oral mani-
festations. (d) The article describes oral manifestations of
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inherited EB; however, the diagnosis of EB is not well justi-
fied or incomplete. (e) The article describes oralmanifesta-
tions of inherited EB; however, themethod to diagnose the
oral manifestation is not standardized, well described, or
incomplete. (f) Cohort already published in previous arti-
cles. (g) Literature review does not provide new clinical
information.
Data collection process
Data were extracted in duplicate by two independent
reviewers. The findings were discussed at a researchers’
consensus meeting.
Data items
The main variables were the types of EB types: (a) EB Sim-
plex, (b) Junctional EB, (c) Dystrophic EB, and (d) Kindler
EB. Whenever possible, the most detailed information on
the subtype of EB was collected.
Within each patient description, the clinical features
registered were:
1. Perioral tissue involvement
a. Microstomia (mouth opening)
2. Intraoral soft tissue involvement
a. Oral ulcers
b. Denuded tongue
c. Ankyloglossia
d. Vestibule obliteration
e. Oral cancer
f. Periodontal disease
g. Saliva
3. Hard tissue involvement
a. Caries
b. Enamel Hypoplasia (localized or generalized)
c. Failure of eruption
d. Occlusal abnormalities
e. Dental maturity
f. Facial growth
g. Bone health
Less frequent findings were also collected.
Risk of bias
The risk of bias is high, as most of the reports do not
present detailed patient diagnosis information (ie, muta-
tion description) and do not use standardized assessment
forms (eg, methods for assessing ankyloglossia).
Results
The search strategy identified 1151 studies: 222 dupli-
cates were removed, 545 articles excluded in first-stage
screening, 182 articles removed in second-stage screening,
and 202 articles were included in the systematic review
(Figure 2.1).
Oral manifestations of EB
The frequency and severity of the oral features of EB vary
according to the subtype of the disease. Most patients will
present some type of vesiculobullous oral lesions, varying
from small, discrete vesicles to large bullae and areas of
granulation tissue. These lesions can be distributed on all
the mucosal surfaces. Patients with the generalized RDEB
are the most severely affected.2,3
The involvement of dental hard tissues depends on the
form of EB. Patients with JEB present with generalized
enamel hypoplasia, individuals with RDEB have signifi-
cantly more caries when compared with other EB types or
unaffected controls,2 and those affected with Kindler EB
have more periodontal disease.4
An early study of 101 individuals with EB demonstrated
that oral blisters were present in 97% of patients with
RDEB, 45% in dominant disease EB (DDEB), 37% in JEB,
and 38% in EBS, while other features such as microsto-
mia were present in 54% of the cases with RDEB, 7% of
JEB and none of the patients with DDEB and EBS.5 There-
fore, studying each type of EB is important to assess each
patient’s prognosis.
2.1 EB simplex (EBS)
Themost recent classification (2020) considers seven auto-
somal dominant and seven autosomal recessive subtypes
of EB Simplex.6 Most of the literature on the oral aspects of
EBS, however, precedes this classification. Therefore, the
text will embrace EBS as a group and only describe spe-
cific subtype informationwhen available. Anecdotally, one
case of cleft lip and cleft palate of an infant with an EBS has
been reported.7
Oral ulcers
Oral mucosal ulceration was described in 20% of patients
with EBS in an early report.8 A more recent case series
reported greater involvement, although oral mucosal
involvement was not always determined by direct clini-
cal examination but by a history of oral ulceration. A total
of 40.3% of the group of 124 patients with EBS had oral
ulcers with 58.6% of those with generalized and 34.7% with
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F IGURE 2 . 1 Flow chart of selected articles
localized EB.3 Oral mucosal involvement was reported to
be more common during the perinatal period, while in
some patients, it persisted during early childhood or even
later.3
Cancer risk
This literature review identified only one report of a 41-
year-old patient with a recessive EBS who developed squa-
mous cell carcinoma (SCC) on the tongue, at a site of fre-
quent blistering9 and a single report of a 66-year old man
with a Merkel cell carcinoma on the right parotid.10
Localized EBS (EBS-loc)
There is no agreement as to the frequency of oral mucosal
lesions in EBS-loc. While Sedano11 in 1989 reported that
this subtype does not give rise to oral mucosal lesions,
Wright in 1991 reported that 34.7% (33/95) of patients with
localized EBS had a history of or presence of oral mucosal
blisters at examination.3 Nine years later, in 2000, Horn
studied a series on 54 patients and described that four indi-
viduals (7%) experienced intraoral blistering.12 Patients can
present ulcers and erosions on their face.13
Intermediate EBS (EBS-intermed)
It has been recognized that patients with this diagnosis
may have occasional intraoral blisters, being less severe
than those of other EB types.11 In a series of 69 individ-
uals, 17 subjects (24%) experienced oral blisters.12 Anec-
dotally, a case report of a 3-year-old child described sev-
eral white lesions and ulcers of various sized on the
buccal mucosa and gingiva, as well as several decayed
teeth.14
EBS intermediate with cardiomyopathy
In 2016, mutations in the gen KLHL24 were first iden-
tified in patients with EBS.15 The latest EB consensus
reclassification published in 2020 classifies patients with
mutations in the KLHL24 gen as EBS intermediate with
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cardiomyopathy. In those patients who were reported in
the first article, the oral mucosa was mildly affected.15 A
recent study including seven patients reported that 43% of
them had common oral ulceration.16
EBS Intermediate with muscular dystrophy
The oral description of individuals with this subtype of
EBS caused by mutations in the gene PLEC encoding
plectin includes hemorrhagic blistering of oral mucosa
since birth17 and a case report of micrognathia, high-
arched palate, and poor dentition with erosions.18
Severe EBS (EBS-sev)
Patients in this group present with more mucosal lesions
than the localized and intermediate subtypes of EBS. A
case series reported history of intraoral lesions in 58.6%
(17of 29) individuals with severe EBS.3 The series reported
by Horn in 2000 included seven patients with severe
EBS: the four infants in the study had intraoral blister-
ing and hoarse cry; there is no intraoral description of the
other three patients. It is reported, however, that sever-
ity of blistering lessened during childhood and adoles-
cence in all patients.12 Lalor in 2018 described that three of
five patients had severe oral blisters as neonate, one only
had oral blistering during infancy, and the fifth patients
had no mucosal blistering.19 Single case reports have also
described frequent oral blistering and lesions affecting
all areas of the oral mucosa, even within a few hours
after birth.20–22 Occasionally, these ulcers are so painful
that the patients are not able to tolerate toothbrushing
due to trauma to the mucosa.21 On the other hand, there
are reports of patients who only report occasional oral
blisters.21 Anecdotally, one patient with multiple natal
teeth and extensive blistering on her body and around her
mouth has been described.23
2.2 Junctional EB (JEB)
The latest EB classification scheme recognizes two major
subtypes: severe JEB (previously known as JEB general-
ized severe, Herlitz JEB) and intermediate JEB (previously
known as JEB generalized intermediate, non-Herlitz JEB).
The classification also recognizes other less common sub-
types and syndromic disorders: localized JEB, inversa JEB,
late onset JEB, laryngo-onycho-cutaneous syndrome (LOC
Syndrome), JEB with pyloric atresia, and JEB with inter-
stitial lung disease and nephrotic syndrome.6 Same as for
EBS, most of the literature on the oral aspects of JEB pre-
cedes this classification. Precise description will be pro-
vided as available.
Peri-oral tissue involvement
Peri-oral and peri-nasal granulation tissue lesions tend to
develop between the 6th and 12th month of life in patients
with severe JEB (Image 2.1). The lesions have been noted
in all patients with severe JEB and tended to resolve dur-
ing or after adolescence in patients who survived (Image
2.2).3,11 They are believed to be pathognomonic for severe
JEB.11
Microstomia
A case series studied the commissure-to-commissure dis-
tance obtaining: 39.2 mm in severe JEB, 46.7 mm in all the
other JEB patients, and 44.7 mm in the healthy controls.
Statistically, these differences were not significant.3 Other
studies on oral functions in EB have revealed that 50%
(3/6)24 and 67% (2/3)13 of the patients had limited mouth
opening.
Intraoral soft tissue involvement
Patients with JEB seem to present with fewer mucosal
lesions on examination.25 However, most patients will
have a positive history of major oral mucosal bullae or
intraoral areas of granulation tissue (83.3% in severe JEB,
91.6% in intermediate JEB).3,26 These lesions might take
several weeks or months to heal. Somewill even take years
to heal. Intraoral scarring is uncommon.2,3,27
Hard tissue involvement
Generalized enamel hypoplasia. Generalized enamel
hypoplasia has been reported in 59 case reports of individ-
uals with JEB,2,25,27–45 as well as 100% of the patients with
JEB in a series of cases (n = 6 severe JEB-H, n = 19 other
types of JEB) (Images 2.3 and 2.4).46 Enamel hypoplasia
can be observed in panoramic radiographs as teeth with
thin, abnormal, severely dystrophic enamel formation
(Image 2.5).25 Some authors suggested that generalized
enamel hypoplasia in EB is pathognomonic for JEB, and
therefore, the teeth phenotype can be used as a guide to
the EB type diagnosis when more precise laboratory tests
are not available.47
The type or severity of enamel defects varies between
individuals. In the series reported by Wright, 66.7% of the
patients demonstrated generalized, rough, pitted enamel
hypoplasia, while the remaining cases showed generalized
thinning and/or furrowing of the enamel.46
Severe forms of JEB have shown a tendency to have
thin (≈ 40 μm), prismless enamel.46,48 While patients with
other types of JEB, on the other hand, present a rather
thicker but porous enamel with pits. The prismatic struc-
ture has been described as normal but interrupted by
marked surface pitting.46,48
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IMAGE 2 . 1 and 2 . 2 Areas of perioral granulation tissue in a 2- and 10-year-old patients with severe JEB
IMAGE 2 . 3 and 2 . 4 Generalized enamel hypoplasia in patients with JEB
Kirkham carried out a chemical characterization of the
enamel of teeth from JEB patients and compared it to that
of unaffected controls. The results showed that JEB enamel
contained a significantly reducedmineral per volume con-
tent, resulting in enamel hypoplasia.49
Enamel hypoplasia have been described in patients
with JEB caused by mutations in the genes encod-
ing laminin-332 (LAMA3, LAMB3, and LAMC2),
α6β4-integrin (TGB4, ITGA6), and type XVII collagen
(COL17A1).32,36,48,50–54 This has been explained due to the
role of these proteins in cell adhesion in the odontogenic
epithelium, which gives rise to ameloblasts, the cells that
produce dental enamel. Laminin-332 plays a vital role in
all the stages of enamel formation. In the presecretory and
maturation stages, it is part of the basal lamina and medi-
ates adhesion of ameloblasts to the enamel matrix in the
IMAGE 2 . 5 Panoramic radiograph showing thin, abnormal,
severely hypoplastic enamel on both dentitions of a 10-year-old
patient with JEB and generalized enamel hypoplasia
secretory stage. Abnormal ameloblast adhesion results in
leakage of serum into the developing enamel leading to the
retention of albumin that inhibits mineralization.33,55,56
The chemical characterization carried out by Kirkham
revealed the presence of serum albumin in JEB enamel, in
contrast to control enamel and enamel from patients with
the dystrophic form of EB, where this was not detected.49,57
Studies by Asaka showed that disruption of the COL17A1
gene leads to abnormal interaction between enamel
epithelium and the underlying mesenchyme, resulting in
a defective ameloblast with a malformed Tomes’ processes
with decreased secretion of enamel matrix at the secretary
stage. At the maturation stage, this disruption in Col17
leads to a delayed calcification and reduced iron deposi-
tion in the enamel. These mechanisms contribute to an
immature and irregular enamel formation.58
Failure of eruption. Failure of teeth eruption has been
noted in three reports.27,39,45 Wright specifies that selected
anterior and/or posterior teeth can be affected.45 This
might be related to the gingiva hyperplasia that has been
reported in 50% of the patients.13
Severe JEB
Oral lesions, including a history and/or presence of blis-
ters, were reported in 83.3% of one group of patients with
severe JEB.3 The reports of newborns suggest that blis-
ters can develop during the first week of life.59 White
plaques, ulcers and erosions on the gingivae, soft palate,
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hard palate, and lips have been reported in individual
cases.60,61
Less frequent findings
A rare case of pyogenic granuloma on the tongue was
reported in young child with severe JEB that had under-
gone allogenic hematopoietic cell transplant. Both granu-
lomas were successfully excised with no recurrence.62
Intermediate JEB
Oral lesions, including a history and/or presence of blis-
ters, were reported in 91.6% of a group of 12 patients.3 Bul-
lae might not be present at examination, but the patient
can have a positive history of affected mucous membranes
in the mouth.63
Hintner, in a report of the previously named gen-
eralized atrophic benign epidermolysis bullosa, GABEB
reported blisters and ulcers on the oral mucosa during
infancy, which caused difficulties eating and performing
oral hygiene; but after puberty, the oral mucosal condi-
tion improved. Few patients had continuous blister forma-
tion on the oral mucous membranes. These blisters healed
without scarring.64
A series of 12 patients with Intermediate JEB caused by
mutations in the gene COL17A1 coding for type XVII colla-
gen described that all 12 patients had amelogenesis imper-
fecta (enamel pitting).65 In the same cohort of patients,
it was reported that two patients occasionally had oral
blisters, while a third patient had no mucous membranes
involvement. There was no reported information on oral
blisters from the other nine patients.65 The presence of
enamel defects in carriers of mutations in COL17A1 has
been reported in two families.66,67
Interestingly, in a family of a patient with Intermediate
JEB due to a mutation in LAMA3, where the affected indi-
vidual presented with occasional oral erosions and enamel
hypoplasia, two healthy carriers of the LAMA3 null muta-
tions also had enamel defects, consisting of roughness and
pits.33
JEB with pyloric atresia (JEB-PA)
All the reports of patients with JEB-PA describe general-
ized enamel hypoplasia34,35 due tomutations in ITGB4, the
gene encoding the ß4 integrin protein.36
Late onset JEB
The systematic literature search performed in this study
only identified one paper describing oral features of late
onset JEB. Although the report does not comply with the
inclusion criteria of a well-documented EB diagnosis (ide-
ally an immunofluorescence or mutation analysis), it was
decided to include the case as it represents the only evi-
dence available for oral manifestations of this rare subtype
of JEB. Two siblings with an electron microscopic study
supporting JEB (blister formed between the dermis and
epidermis above the dermal membrane) presented yellow-
ish enamel defect of the entire dentition.68
LOC syndrome
Several reports have described generalized enamel
hypoplasia, with small, yellow hypoplastic teeth.69–72
2.3 Dystrophic EB (DEB)
DEB may be inherited as a dominant (DDEB) or reces-
sive (RDEB) trait. Generally, RDEB is more severe than
dominant disease (DDEB); however, there is considerable
phenotypic overlap between types. It is caused by muta-
tions in COL7A1, the gene coding collagen VII, the major
component of the anchoring fibrils at the cutaneous base-
ment membrane zone. The hallmark of DEB is scarring
following blistering, both in the skin and in a variety of
mucosae.6
Patients with DEB present more oral manifestations as a
consequence of mucosal fragility and scaring than patients
with the previously described types. A comparative study
published in 1992 (based on clinical diagnosis only) com-
pared microstomia (limited mouth opening) and lingual
adhesions (ankyloglossia) in a cohort of 197 patients with
EB, identifying both features only in individuals affected
with DEB.73
Dominant DEB (DDEB)
Soft tissue involvement
There is no agreement about the extent of oral mucosal
involvement in DDEB. One review stated that 20% of
patients have oral mucosal bullae,11 while another case
series indicated that 71.1% to 89.6% of patients may have
a history of or oral clinical features of oral mucosal blister-
ing (Images 2.6 and 2.7).3,26 Single case reports vary from
no mucosal involvement at all74 to frequent intraoral bul-
lae as a result of minor trauma,75 painful oral ulcers, severe
gingival inflammation, erosive lesions in vestibular region,
and restricted mouth opening (microstomia, no measure-
ment provided).76 Of note, significant scarring, vestibular
obliteration, and ankyloglossia do not seem to be long-term
complications of oralmucosal ulceration/blisters.3,76 How-
ever, the reduction and absence of keratinized gingiva has
been described.13,75
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IMAGE 2 . 6 and 2 . 7 Blood filled bullae on the tongue in patients with DDEB
Hard tissue involvement
Patients with DDEB do not seem to be at increased risk of
caries.2,26
Recessive DEB (RDEB)
The current classification scheme (2020) recognizes six
subtypes of RDEB: severe, intermediate, inversa, localized,
pruriginosa, and self-improving RDEB.6 The severe sub-
type presents the more extensive oral manifestations. As
the classification scheme of EB has been updated four
times in the last 20 years, and the literature describing oral
features precedes the current scheme, there is some over-
lap of clinical descriptions.
Generalized forms of RDEB
The following text includes patients with severe RDEB
(previously RDEB generalized severe, Hallopeau-Siemens
RDEB) and intermediate RDEB (previously known
as RDEB generalized intermediate, non-Hallopeau-
Siemens RDEB).
Perioral tissue involvement
Microstomia (mouth opening). Progressive26,77 microsto-
mia affects almost all patients with generalized RDEB
(Image 2.8).2,3,24,26,27,78–117 Microstomia is not unique to
generalized RDEB, and it might also be present in inversa
RDEB and severe JEB.2,26 The degree of microstomia of
patients with severe RDEB has been reported to be severe
in over 80% of affected individuals.13,82,85,87,92–94,115,117 Dif-
ferent techniques to measure microstomia have been
used,3,24,82,91,118 therefore comparing the results is not fea-
sible.
The precise cause of microstomia in severe RDEB is not
clear, although it seems to reflect scarring of the buccal
and labial mucosa and commissures.3,26,111,115,119 In several
patients, fibrous scar bands can be palpated bilaterally at
the commissures113 and the buccal mucosa.95 Microsto-
IMAGE 2 . 8 Limited mouth opening in RDEB
mia can give rise to a wide variety of functional problems,
including difficulties in eating, speech, and oral hygiene
maintenance. Furthermore, dental treatment and general
anesthesia can be complicated, and the aesthetics of the
lower face is compromised.2,82,84,120,121
Intraoral soft tissue involvement
Oral ulcers and blister. The oral mucosa of patients
with generalized RDEB is extremely friable and may
slough off easily when touched.86,116 Recurrent oral
mucosal blistering is common, affecting almost all
patients78,80,82–84,87,89,92,95–99,101–103,106,107,110,111,113,114,119,122–126
The blisters may be fluid- or blood-filled and arise at any
oral mucosal surface, especially the tongue (Images 2.9–
2.12).82,91,102,106 Some lesions can be caused by sharp
edges of broken teeth or restorations.92,105 Patients may
not allow clinicians to touch their oral mucosa afraid of
producing new wounds and causing pain.100,107 Others
may be afraid of brushing their teeth due to painful blisters
in their mouth.126 In newborns, these erosions can make
oral feeding very challenging, requiring special feeding
bottles.127 Older patients may be able to tolerate a normal
diet but frequent occurrence of oral ulcers and dysphagia
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IMAGE 2 . 9 Blood filled bullae on the tongue of a patient with
RDEB
IMAGE 2 . 1 0 Bullae on the buccal mucosa of a patient with
RDEB
IMAGE 2 . 1 1 Serous bullae covering 3/5 of the tongue of a new-
born with RDEB
IMAGE 2 . 1 2 Blood filled bullae on the palate of a patient with
RDEB
IMAGE 2 . 1 3 Absence of tongue papillae in RDEB
IMAGE 2 . 14 Ankyloglossia in RDEB
can limit their oral intake making them resort to liquid
diet.110
Absence of tongue papillae (depapillated tongue,
denuded tongue). Tongue papillae are absent. This
is often referred to as complete depapillation (Image
2.13).3,26,27,81,82,84,85,91,95,103,106,108,110,111,113,114,117,119,122,125
Absence of palatal rugae. The absence of palatal rugae has
also been described in patients with generalized forms of
RDEB.95,103
Ankyloglossia. Ankyloglossia presumably sec-
ondary to ulceration and scarring is com-
mon, and indeed may affect all patients (Image
2.14).2,3,26,27,79–82,88,91–95,99,101,105,106,108,110,114,115,117,124,128
A study on oral functions revealed that only 7 of 10
patients with RDEB could stick their tongue forward, with
an average of extending the tongue only 6 mm beyond the
teeth. In the same study, only 2 of 9 patients could put the
tip of the tongue on the left cheek and 1 of 8 on the right
side.24 This severe ankyloglossia contributes to the feeding
difficulties of newborns, requiring a special bottle to feed
adequately.128
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IMAGE 2 . 1 5 Obliteration of the labial vestibule in RDEB
Oral vestibule obliteration. The scarring in
generalized forms of RDEB can give rise
to obliteration of the labial and buccal
vestibules,2,3,27,78,79,81–85,89,91–95,101,103,105,108,112,117,119,124
and hence, has the potential to compromise oral hygiene,
dental treatment, and the wearing of removable prosthetic
appliances (Image 2.15).
Cancer risk. SCC has been described as the leading cause
of death in patients with severe RDEB.129 Few cases affect-
ing the oral cavity have been reported. The tongue is the
most affected site, although tumors on the lip and the hard
palate have also been reported. The age of diagnosis ranged
from 25 to 54 years of age. At least three cases have been
fatal.3,26,88,130,131 Of note, Oral SCC has also been described
in recessive EBS9 and Kindler EB.132–138
Periodontal disease. Extensive plaque deposits
have been reported on the teeth of most
patients.27,78,80,83,85,86,98,102,106,110,117,126,139
Mean plaque score measured using a modification of
the index of O’Leary140 revealed higher values for patients
with DEB (n = 23; 18 RDEB, 5 DDBE) in the primary (33.7
± 31.3) and secondary dentitions (28.6 ± 31.6) when com-
pared to a control group (1.8 ± 3.3/4.6 ± 5.6, respectively)
(Image 2.16).141
Gingivitis or gingival inflammation is often
reported.98,105,106,110,125 Mean gingivitis scores (using
the simplified gingival index) have been found to be sig-
nificantly greater in patients with DEB (n = 23; 18 RDEB,
5 DDEB) in both primary (21.5 ± 29) and permanent
dentitions (27.5 ± 34.9) when compared to a control group
(0.00/2 ± 4.6, respectively).141 Fortuna, in 2015, found that
erythema was the most prevalent gingival lesion (66.2%)
in severe generalized RDEB.142 There does not appear
to be an increased risk of periodontal membrane and
bone involvement in RDEB.83,84 Puliyel, in 2014, found
IMAGE 2 . 1 6 Extensive plaque deposits and gingival inflam-
mation in RDEB
deep pockets on periodontal charting. It was explained,
however, that they corresponded to pseudopockets, pri-
marily on posterior teeth. Gingival inflammation and
bleeding were found on all teeth. Plaque and calculus
accumulation were heavy, especially in the lingual and
buccal surface of mandibular posterior teeth. Gingival
recessions were absent.95 Only Al-Abadi has reported
increased mobility and alveolar bone loss around lower
anterior teeth.108 A retrospective study on dental implants
published by Peñarrocha in 2020 demonstrated a success
rate of 97.5%. Even though 50% of the implants showed
mucositis and bleeding upon probing was observed in
67.5% of the implants, probing depth was maintained at
1-3 mm in 96.2% of the implants and 52.5% of the implants
showed 0 mm retraction of the peri-implant mucosa after
a mean follow-up of 7.5 years. Keratinized mucosa in the
buccal zone of the implants was noted in 62% of the cases,
while 38% showed no keratinized, mobile peri-implant soft
tissue. Peri-implant bone loss after 7.7 years of follow-up
was only 1.65 ± 0.54 mm.139
Saliva. A study conducted by Leal and coworkers in 2016
compared mucosa hydration, salivary flow, pH, and buffer
capacity of individuals with EB to a control group, finding
no significant difference between the groups.118 Research
conducted by Wright found no changes in salivary flow
rate. In that cohort of patients with RDEB, significantly
elevated salivary IgA, albumin, and total protein levels
were noted; most likely related to the high prevalence of
oral blistering. They found no evidence to support an asso-
ciation between salivary function and dental caries.143
Hard tissue involvement
Caries. Patients with RDEB have significantly higher
caries scores (decay-missing-filled [DMF]) index than
control patients (Images 2.17 and 2.18).2,26,79,92,118,141
Single-case reports also often highlight increased pres-
ence of decayed teeth.96–99,102,103,105–108,110,111,116,125,126
Some patients have been reported to have pain,96,105,108
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IMAGE 2 . 17 and 2 . 1 8 Severe caries in a 12-year-old and a 20 years old patient with RDEB
abscess,91,96,108,126 and/or cellulitis secondary to periapical
infection,96,122 while other patients have lost their entire
dentition due to caries,100,104,111 presenting very small
edentulous ridges.100
Risk factors associated with this elevated caries index
include: soft diet, limited mouth opening, and contrac-
ture of the fingers causing difficulty in maintaining oral
hygiene.118 It has been noted that extensive caries can be
found specifically on the lingual surface.95 A study on the
mineral, carbonate, protein content, and amino acid com-
position of the enamel of teeth from patients with RDEB
showed normal chemistry.57
Occlusal abnormalities. A variety of occlusal anomalies
have been described in RDEB including increased overjet,
overbite,82 severe crowding,3,79,82,91,92,107 cross-bite molar
relationship,79,102 and class II skeletal malocclusion.91,102
Some of the anomalies may be due to reduced alveolar
arches (secondary to growth retardation) and collapse of
the dental arches (secondary to soft tissue constriction).144
A cephalometric study of 42 patients with RDEB found
significantly smaller jaws in this patient cohort,145 thus
adding weight to the suggestion that significant dentoalve-
olar disproportion and dental crowding are features of
RDEB.
Dental maturity and agenesis. Two studies have been
published on dental maturity and dental develop-
ment in patients with RDEB finding no significant
delay.146,147 Single-tooth agenesis has been reported in
three cases.85,113,148 It is not possible to establish if the
incidence is different to the general population.
Facial growth. A cephalometric analysis of 42 patients
with severe RDEB indicated that this subtype of EB gives
rise to a significantly reduced maxillary length, mandibu-
lar length, middle facial height, and lower facial height
when compared to the published normal values. Saddle
and nasolabial angles are significantly greater in RDEB.145
The changes in facial skeleton may reflect reduced nutri-
tional intake (feeding problems) and subsequently reduced
bone growth.145 Additionally, or alternatively, peri-oral
soft tissue scarring during early childhood may result in
reduced size of the jaws.149
Bone health/osteoporosis. Osteoporosis has been increas-
ingly identified in patients with this form of RDEB.150 In
one report, radiographic records and computerized tomog-
raphy scans of the jaw revealed extensive bone atrophy of
the jaws in six out of six patients.94 During surgery, the
alveolar ridges of these patients were found to be atrophic
in all cases.93,94
Less frequent findings. A sialolithmeasuring 8mm× 7mm
was reported in the submandibular gland of a 17-year-old
female with RDEB. The removal was challenging due to
her microstomia and ankyloglossia.151
Inversa RDEB
RDEB inversa subtype is an uncommon form of EB.
Patients present with mucosal blistering (especially sub-
lingually), ankyloglossia, absence of tongue papillae,
absence of palatal rugae, partial obliteration of the
vestibule, microstomia secondary to scarring, andmucosal
milia.26,97,152–154 Of note esophageal involvement and dys-
phagia affected 90% of one group of 10 patients.152
Hard tissue involvement
A significantly higher prevalence of caries (decayed, miss-
ing, and filled surfaces index: DMFS 50.9) than the control
group (DMFS: 12.8) was reported in a study of 10 patients.
Enamel abnormalities have only been reported in 1 of 14
patients having a localized enamel defect of one tooth.152
2.4 Kindler EB (KEB) (previously
Kindler syndrome)
Peri-oral tissue involvement
Perioral areas can present with erosions, crusts, and
chronic cheilitis.132,133,135,138,155-164 Glandular cheilitis of the
lower lip have been reported in a 7-year-old patient.159
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IMAGE 2 . 1 9 Severe microstomia in a 33-year-old patient with
Kindler EB
IMAGE 2 . 2 0 Obliteration of the labial vestibule in a 15-year-
old patient with Kindler EB
Microstomia
Microstomia, or restricted mouth opening, probably due
to fibrosis of the commissures, has been reported in sev-
eral patients with KEB (Image 2.19).4,132,135,138,155,156,165-172
However, many patients do not complain of this functional
problem. No studies have been identified on the severity or
prevalence of this feature.
Intraoral soft tissue involvement
While some patients, particularly younger cases, do not
report involvement of the oral mucosa,173–176 others report
few ulcers164,177,178 and a third group presents fragile
mucosa and painful ulcers scattered throughout the oral
mucosa, affecting the alveolar ridge, soft palate, lip, and
floor of the mouth.133,162,164,165,179,180
Oral vestibule obliteration
Partial obliteration of the oral vestibule, also described as:
“synechiae between the lips and the gums,” “adhesions
between the lips and gingiva,” or “atrophy of the buccal
mucosa” has been described in several patients with KEB
(Image 2.20).4,132,133,138,155,161,166,167,169–172,181–183
Reticular pigmentation on the cheek,160,163 white
hyperkeratotic papules on the buccal mucosa,165,184 and
IMAGE 2 . 2 1 Severe periodontitis in a 33-year-old patient with
Kindler EB
xerostomia160 are least frequent findings. Penagos in 2004
only found leukokeratosis of the oral mucosa in 3 of 26
patients, supporting the statement that this finding is
rather uncommon.185
Periodontal disease
Special attention has been given to periodontal disease,
which was initially reported in two patients.155,169 There-
after a series of 18 patients was compared to healthy
controls, and revealed that patients with KEB have a
higher prevalence (72% vs. 46%), earlier onset and faster
progression of periodontitis (Image 2.21).4 The same
cohort was followed up and published with 26 individuals,
of those 81% developed severe periodontitis with prema-
ture loss of teeth.185 Periodontitis, tooth loss, mucosal
involvement such as microstomia, and caries have been
reported in all other case series as well.186–188 Multiple
single-patient reports also highlight gingival health as
a major concern,132,133 including a 14-year-old patient
who lost all of her teeth due to severe periodontitis.161
Most of the descriptions of periodontal disease in patients
with KEB have been published by medical teams;
therefore, the authors use more general terms such as:
halitosis,164,177 gingivitis,156,160,163,164,180–183,189,190,191 severe
gingivitis,164,168,192,193 erosive stomatitis,194 desquamative
gingivitis,155,160,165 easy bleeding,155,157,164,167,180–182,195,196
gingival hypertrophy,162,178,197 periodontitis,135,157–159,162,164,
178,180,184,190,198–201 severe periodontitis,161,165,173,192,195,196
severe periodontal bone loss,155 “missing teeth,” “loss
of teeth,” or “poor preservation of teeth,”135,158,160,161,
167,168,173,184,190,195,196,200,202 and gingiva with pseudomem-
branous necrotic and bleeding areas.173 Interestingly,
and in contrast to RDEB where poor hygiene is widely
reported, only few reports describe poor dental hygiene;
even though the severity of periodontal disease in KEB is
more complex (Image 2.22).168,180
Reports written by dentists, and more specifically
periodontists, provide more insight into the periodon-
tal aspects of Kindler EB. A 16-year-old patient with
KEB presented advanced early-onset periodontal disease.
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IMAGE 2 . 2 2 Generalized gingival inflammation in a 13-year-
old patient with Kindler EB
Her gingiva bled excessively during toothbrushing and
even spontaneously. All her deciduous teeth exfoliated
between 4 and 7 years of age and the permanent
right mandibular central incisor exfoliated spontaneously
when she was 10 years old. After oral examination, the
diagnosis of periodontitis associated with systemic dis-
ease was established.203 Another series of five related
patients aged 6 to 14 included clinical features, peri-
odontal charts, and radiographs. Microstomia was iden-
tified in all patients. The 14-year-old patient had his two
lower first molars extracted due to bone loss and gingival
recession. Panoramic radiograph revealed discrete alveo-
lar bone resorption in all four patients aged 6 to 12 years
old and severe alveolar bone resorption in the 14 year old.
Periodontal examination showed severe gingival inflam-
mation, with periodontal pockets (>4 mm) in the patients
aged 6 to 10 and aggressive periodontitis in the 12- and 14-
year-old patients, with deep pockets (≥7 mm). The gin-
giva was thin and fragile, and the epithelium sloughed
with minor abrasion. With periodontal treatment and reg-
ular dental care focused on good oral hygiene periodon-
tal health may be improved and alveolar bone loss can be
reduced. Regular dental visits are therefore very impor-
tant to control desquamative gingivitis and aggressive peri-
odontitis in patients with KEB.204
Caries
Caries have only been mentioned in two reports.159,183
There is no suggestion that patientswithKindler EBwould
have a prevalence of caries different than the healthy popu-
lation.Of interest, oral rehabilitationusing dental implants
have been reported once, with failure after 6 years.160
Cancer risk
Oral SCC can also present in patients with Kindler EB.
To date, at least seven cases of oral SSC have been
reported,132–138 two being fatal.133,135 The age of diagnosis
has ranged from 34 to 55 years of age and the affected
sites include hard palate (one extending to the right
cheek),132,135 buccal mucosa,134 upper lip,137,138 and lower
lip.133,136
Discussion
The evidence gathered in this systematic review demon-
strates that the oral findings vary according to the type
and subtype of EB (Table 2.1). While patients with JEB,
for example, present with generalized enamel hypopla-
sia as the main clinical challenge, individuals with RDEB
present with extremely friable mucosa and severe scaring
consequences and those with Kindler EB have early-onset
periodontal disease. This is very important, as it helps to
plan every patient’s treatment considering their unique
features. As EB is the umbrella term for the condition,
knowing the precise type and subtype of the condition is
of upmost importance for the dental clinician to plan the
long-term care of each patient. Pediatric dentists will lead
the team for young patients and special care dentists will
lead the team taking care of adults. The information gath-
ered in this article will help guide the inclusion of differ-
ent dental specialists, for example including oral rehabili-
tation specialist in teams looking after patients with junc-
tional EB, orthodontists in teams looking after children
with RDEB and periodontist for teams caring for patients
with Kindler EB.
A major limitation of this review is the lack of pre-
cise information on the diagnostic laboratory tests per-
formed on several of the case reports. For example, often
the clinical diagnosis is described, but there are no IFM or
mutation analysis results to support it. On the other hand,
some reports include mutation analysis (eg, mutation in
gen COL7A1) but do not specify the clinical subtype of
DEB the patient lives with. To overcome these limitations,
dentists are encouraged to report their clinical cases with
precise diagnostic information, including all the laboratory
tests to support the diagnosis, aswell as considering the lat-
est classification scheme of EB.
A second difficulty is the lack of standardized assess-
ment forms to evaluate oral features unique for EB
such as vestibule obliteration, ankyloglossia, microstomia,
absence of tongue papillae, and palatal rugae. To date
there is the EB oropharyngeal severity score;205 however,
that score assesses the severity of the condition, and does
not describe the clinical features. A standardized EB oral
assessment form would be of great benefit for the EB com-
munity.
This systematic review highlights the importance of
multidisciplinary care. Both dental and medical teams
need to communicate better on the precise diagnostic
aspects of both the skin and oral conditions.
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TABLE 2 . 1 Main oral features of the major EB types
EB Simplex Junctional EB Dominant Dystrophic
EB
Recessive Dystrophic
EB
Kindler EB
Perioral tissue Can present ulcers
and erosions on the
face.
Perioral and perinasal
granulation tissue
(mainly in children
with severe forms).
Can present some
ulcers and erosions
on the face.
Most patients present
ulcers and erosions at
different healing
stages on their face.
Erosions, crusts, and
cheilitis can be
observed.
Microstomia (mouth
opening)
NDE Has been reported in
50% to 67% of the
patients.
NDE Progressive
microstomia
develops. Severe in
80% of the patients.
Can be present. Not
all patients will
develop this
condition.
Oral ulcers Localized EBS: 7% to
35% of the patients
have positive history.
Intermediate EBS:
24% to 43% of the
patients have
positive history.
Severe EBS: 59% to
80% of the patients
have positive history.
Severity tends to
lessen with age.
Few lesions on
examination,
but high history of
major intraoral bullae
or granulation tissue:
83% to 91%. Slow
healing process,
intraoral scarring is
uncommon.
Present in 20% to 90%
of the patients.
Present in 97% of the
patients, can affect all
intraoral surfaces.
Varies among patients
from no ulcers to
painful ulcers
throughout the oral
mucosa.
Denuded tongue Not reported Not reported Not reported Tongue papillae are
absent. Absence of
palatal rugae is also
reported.
Not reported
Ankyloglossia No significant
scarring observed.
No significant
scarring observed.
No significant
scarring observed.
Is common, may
affect all patients.
No significant
scarring observed.
Vestibule
obliteration
No significant
scarring observed.
No significant
scarring observed.
Reduction of
keratinized gingiva
has been reported.
Severe obliteration of
the vestibule is
common, may affect
all patients.
Partial vestibule
obliteration has been
described in several
patients.
Oral squamous cell
cancer (OSCC)
Only one case
reported, 41 year old.
Not reported Not reported OSCC has been
described on tongue,
lip, and hard palate.
Age range 25 to 54.
OSCC has been
reported on hard
palate, buccal
mucosa, upper and
lower lip. Age range
34 to 55 years.
Periodontal disease NDE Gingival hyperplasia
observed in 50% of the
patients.
NDE Extensive plaque
deposits and
gingivitis are often
observed.
High prevalence,
early onset, and fast
progression of
periodontal disease.
Caries NDE NDE NDE Significant higher
caries scores.
NDE
Generalized Enamel
Hypoplasia
Not reported Generalized Enamel
Hypoplasia in all
patients. Type and
severity vary from
pitted to generalized
thinning and
furrowing of the
enamel.
Not reported Not reported Not reported
(Continues)
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TABLE 2 . 1 (Continued)
Failure of eruption Not reported Can be present. Not reported Not reported Not reported
Occlusal
abnormalities
NDE NDE NDE Smaller jaws have
been observed on
cephalometric
studies. Severe
crowding is often
reported.
NDE
Abbreviation: NDE, No difference expected compared to unaffected population.
Conclusions
Oral manifestations of inherited EB have unique patterns
of involvement associated with each subtype of the con-
dition. Understanding each subtype individually will help
clinicians when planning initial and long-term care of
those individuals. Furthermore, in a rare disorder with
multiple comorbidities, it is vital to treat each patient with
EB using a multidisciplinary care approach with clear
regular communication between health care professionals
involved in the patient’s care.
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Introduction
Children and adults with EB present fragile skin and
mucosa, as well as specific oral features, as described in
the previous chapter, requiring a special approach from the
dental perspective. The present article is and update of the
2012 CPG on oral health care for patients with EB1, includ-
ing new evidence and a wider panel of international clini-
cal experts. The present CPG follows a standardmethodol-
ogy based on a systematic review of the currently available
scientific evidence.
Aim
To provide the users with information on the current best
practices for managing the oral health care of people living
with EB.
Health question covered in the guideline
Dopatientswith EBneed specific precautions or treatment
modifications compared to healthy individuals to avoid
trauma to the skin and mucosa while providing dental
care?
Users
Specialists in Pediatric Dentistry, Special Care Dentistry,
Orthodontics, Oral and Maxillofacial Surgery, Endodon-
tics, Periodontics, Rehabilitation and General Dental Prac-
titioners, Dental hygienists, Pediatricians, Dermatologists,
Otolaryngologists (ENT), Nurses, Dietitians, Speech and
Language Therapists, parents, and those living with Inher-
ited Epidermolysis Bullosa.
Target group
These guidelines can be applied to all patients diagnosed
with EB. As such, the guideline considers information for
all four major types of EB: EB Simplex (EBS), Junctional
EB (JEB), Dystrophic EB (DEB), and Kindler EB (KEB).
Methodology
Systematic Literature Searching
Literature sources
A systematic literature reviewwas performed to identify all
the oral care and treatment precautions for patients with
EB. The literature search ranged from 2010 to March 2018.
Consulted sources included the electronic databasesMED-
LINE (2010 toMarch 2018), EMBASE (2010 toMarch 2018),
CINAHL (2010 to March 2018), The Cochrane Library
(2010), DARE (2010), and the Cochrane controlled tri-
als register (CENTRAL) (2010). In addition, hand search-
ing journals, reviewing conference proceedings, and other
guidelines sources such as DEBRA International Guide-
line depository were carried out. The reference lists of
all papers for relevant citations were reviewed. When all
the relevant studies were identified, they were sent to the
experts to review for completeness.
Selection criteria of the articles
Selection criteria of the articles: primary or secondary arti-
cles in which the main topic is oral care and precau-
tions during dental treatment (diagnosis, and/or treatment
and/or prognosis) of patients with EB, published between
2010 and 2018 in any language.
Search strategy
To identify studies for this review, detailed search strategies
were based on the search strategy developed forMEDLINE
but revised appropriately for each database. The search
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F IGURE 3 . 1 Method used for formulating the recommendations as described on the 50 Guideline Developer’s Handbook, NHS Scottish
Intercollegiate Guidelines Network SIGN. Revised Edition January 20082
strategy used a combination of controlled vocabulary and
free text terms based on:
#1 "Epidermolysis Bullosa"[Mesh],
#2 ((Epidermolysis[tiab] OR Acantholysis[tiab])) AND
Bullosa[tiab]
#3 "Dentistry"[Mesh]
#4 "Oral Health"[Mesh]
#5 "Mouth Diseases"[Mesh]
#6 "Dentistry"[tiab]
#7: #1 OR #2;
#8: #3 OR #4 OR #5 OR #6;
#9: #7 AND #8;
#10: #9 AND ("2010/11/01"[PDat]: "2018/03/01"[PDat]).
Methods used for formulating the recommendations
To formulate the recommendations of the selected studies,
the SIGN system was used as described on the 50 Guide-
line Developer’s Handbook, NHS Scottish Intercollegiate
Guidelines Network SIGN. Revised Edition January 2008
Figure 3.1.2
Guideline development process
The information from the selected studies was gathered in
a draft document by the clinical leads and methodologists.
The draft document was analyzed and discussed at a con-
sensus meeting held in Dubai on August 30th, 2018, by the
clinical leads, clinical experts, and patient representatives
guided by the methodologists as described in Tables 1-4
(page 2 to 4). The consensus report was reviewed by exter-
nal specialists and health care professionals from the mul-
tidisciplinary team (Table 5, page 4), as well as patients and
representatives from the DEBRA association groups from
Australia, Brazil, New Zealand, Spain, and United States
(Table 3, page 3). They reviewed the document to ensure
that the degree to which the evidence addresses patients’
concerns is reflected in the guideline. The final versionwas
piloted in four centers in four different countries for three
months as described in Table 6 on page 4 (September 2019
to December 2019).
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Guideline implementation and monitoring
Implementation barriers
According to the context of implementation of this guide-
line, some barriers to be considered are:
▪ Access to training in EB specific issues.
▪ Insufficient availability of health services in some parts
of the world.
▪ To improve implementation (to reduce barriers) a broad-
cast of the guideline will be developed by the guideline
development panel and uploaded for open access on DI
web page.
▪ Dentists experts in EB should be encouraged in organiz-
ing training for local dentists to motivate them to treat
people with EB and give them confidence.
Guideline monitoring and/or auditing criteria
The implementation of these recommendations could be
monitored and evaluated through audits and completing
of the “CPGEvaluation Form: Pre-implementation” (avail-
able at https://surveyhero.com/c/aabc0100). The panel
recommends clinical sites to conduct prepractice audit,
implement the CPG, and reaudit to test improvements.
Audit tools can be used from SIGN35. DEBRA Interna-
tional would value your feedback on the site findings to
continue to improve CPG quality.
Further areas of research
∙ Continuous follow-up of the recommendations stated in
this guideline.
∙ Treatment of oral ulcers in patients with EB.
Guideline updating procedure
The guideline will be updated every 5 years after its sec-
ond version. If new relevant evidence is detected before the
update, the information will be published on the web site
http://www.debra-international.org/. The team in charge
of this update will be formed by Prof. Susanne Krämer and
Prof. James Lucas in 2025.
3.1 Oral care for patients with
inherited epidermolysis bullosa
Introduction
A preventive protocol is today’s dental manage-
ment approach of choice.3–5
The approach to dental treatment for patients with EB,
in particular for those with the more severe types, has
changed dramatically over the last 40 years. Crawford et al
in 19766 considered extraction of all teeth to be the treat-
ment of choice for patients with RDEB. Two decades later,
in 1999, Wright7 declared that it was possible to manage
dental abnormalities successfully with a combination of
anesthetic and restorative techniques. In 2008, Skogedal
et al4 advocated that caries can be successfully prevented
in patients with RDEB by continuous follow-up aimed at
dietary advice, oral hygiene habits, frequent professional
cleaning, and fluoride therapy. For those adult patients
who did not successfully access a preventive approach and
have lost their teeth, Peñarrocha and coworkers demon-
strated a high success rate of implant supported complete
oral rehabilitation.8
Importance of oral preventive care anddental
treatment: Patient perspective
This list was ordered according to the prefer-
ences of the patients and their representatives in
the consensus meetings hold in Santiago in 2010
and restated in the consensus meeting in Dubai
2018.
1. To prevent and treat pain and infection. This
is important considering that patients with oral
pain will reduce their nutritional intake.
2. To improve aesthetics and self-esteem.
3. A healthy dentition improves the patient’s abil-
ity to chew and swallow that improves the
nutritional status. Maintaining a functional
dentition also reduces the potential for oral and
esophageal soft tissue damage through more
efficient mastication.
4. Improved phonetics: when anterior teeth are
restored, allowing for better positioning of the
tongue.
5. Improved swallowing: maintaining a healthy
dentition provides the structures needed for
oral functioning, more precisely to complete
the preparatory phase of swallowing.
6. Maintaining a harmonious relationship
between teeth stabilizes the occlusion for bet-
ter function, aesthetics, and allows for better
hygiene.
3.1.1 Access to dental clinic
Accessibility of dental care can be limited for some
patients. Although in most developed countries, dental
care is presumed to be guaranteed, it remains a privilege
for many patients globally. There is a lack of knowledge
35
about the disease in the dental profession9 and other health
care professionals. Dental care can be complicated by the
fears of both the patient and the dentist.10 Providers who
regularly care for patients with EB find allowing plenty of
time and being very gentle can improve the patients con-
fidence, and treatment success. For example, it is impor-
tant to pay attention to the surface that the patient is lay-
ing on, how the patient’s face is touched, or head is held.
Even the simplest of procedures, such as an oral exam,
takes longer due to the limited oral access and the discom-
fort or fear of developing blisters secondary to soft tissue
manipulation.
The clinic must be of easy access for patients using
wheelchairs and walking frames.
If the patient must travel a long distance to attend
the specialist dentist in the EB unit, a shared care
approach can be arrangedwith a local dentist, who
can provide more regular preventive care.
3.1.2 Early referral
Dental care is part of the multidisciplinary team in
EB, and therefore patients should be referred to
the dentist immediately upon diagnosis. Patients
should be referred to the dentist before oral prob-
lems present (ideally 3 to 6months); as early refer-
ral and close follow-up are the key to keeping
patients as healthy as possible from the oral point
of view.
The first consultation should be aimed at:
a. Education of the parents and caregivers: Counseling on
diet (including sugar free medications), oral hygiene
routines (Image 3.1), fluorides, technical aids, and oral
manifestations of EB. This preventive advice should be
provided even before the teeth erupt (Image 3.2).
b. Early diagnosis of enamel abnormalities such as those
seen in junctional EB (JEB). This is possible as soon as
the first primary tooth erupts (Image 3.3).
IMAGE 3 . 1 Early oral hygiene instruction with a finger guard
brush
IMAGE 3 . 2 Two-week-old newborn with severe RDEB. Early
diagnosis and education to parents on bullae management
IMAGE 3 . 3 Early diagnosis of generalized enamel hypoplasia
in an 8 months old child with JEB
c. Early diagnosis of tooth crowding, mainly in recessive
dystrophic EB (RDEB).
d. Early diagnosis of incipient caries lesions.
Patients with EB should be referred to a dentist as
early as possible to identify any feature related to EB that
needs special attention, for example, generalized enamel
hypoplasia.7,10–12 This enables dentists to start preven-
tive programs and reduces the risk of developing dental
diseases.13,14 Many case reports have shown that patients
visit the dentist only when they already have several cari-
ous lesions or pain.11,15–18
3.1.3 Oral assessment
Dental evaluation can be aimed at: (a) identifying treat-
ment needs, (b) identifying oral features of EB, or (c) mea-
suring disease activity and structural damage (ie, severity
of the disease).
The Epidermolysis Bullosa Oropharyngeal Severity
Score (EBOS) was developed to fulfill the third aim:
quantifying the oropharyngeal severity in different
types/subtypes of EB, rather than any possible scarring
phenotype.19,20 This could be an important tool when
studying the impact of different therapies on the clinical
features of the condition. The score has shown strong
intraobserver reliability19 and a lower interobserver
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reliability.21 The score was designed to evaluate the key
features of disease activity: erythema, atrophy, blister-
ing, and erosion and ulceration; as well as the presence
or absence of four clinical parameters: microstomia,
ankyloglossia, and intraoral scaring such as vestibular
obliteration and enamel hypoplasia.19 Later publications,
however, have discussed whether enamel hypoplasia, for
example, measures disease severity or only correlates to
altered genes that cause structural damage of the enamel.
It has been proposed to either evaluate it separately in
another scale or considered as a different measure.22
Also, it is still to be confirmed whether buccal vestibule
and floor of the mouth evaluation should be left or
removed from the EBOS scale.22 Studies using this tool
have not found strict genotype-oropharyngeal phenotype
correlations in DEB.23
Patients with RDEB and Kindler EB are at
increased risk of developing intraoral SCC.
Screening is important as early as during the
third decade in RDEB7,24–27 and fourth decade in
KEB.28–34
3.1.4 Behavioral support
Dental treatment can be a challenge due to sensitivity of
the mucosa, constant presence of blisters, risk of causing
new lesions, microstomia,35,36 limited ability for full coop-
eration from the patient, and risk of causing new lesions
during protective stabilization due to the fragility of the
skin. With appropriate behavioral support, patients can
gain confidence in the dental team and cooperate to the
best of their ability with treatment.14 Behavioral support
should be patient centered and must involve the whole
dental team who should agree on goals and roles and
ensure that any plan to facilitate care is proportionate to
the benefits of the proposed treatment.
As sedation and general anesthesia are techniques often
used for providing dental treatment for patients with EB,
a whole chapter has been dedicated to that topic in this
special issue of the journal: Chapter 5: Sedation and anes-
thesia for adults and children with EB undergoing dental
treatment—Clinical Practice Guidelines.
3.1.5 Skin management
There are some general aspects dentists should consider
when assessing or treating patients with EB to reduce
the occurrence of new blisters and wounds. The environ-
ment should be cool and air conditioned as overheating
can increase skin fragility.37 At any age, no tape or adhe-
sive should be applied directly onto the skin; nonadher-
ent wound dressings can be used instead (see table 5.1 on
page 75).38,39 Babies with EB should be lifted by placing
one hand behind the child’s bottom and one hand behind
the neck, rather than from under the arms, to minimize
friction and blister development in this area. The patient
should be transferred by gentle lifting rather than sliding.37
A topical barrier cream or emollient such as Vaseline R©
(Unilever, London, UK) or Linovera R© (B.Braun, Melsun-
gen, Germany) should be used when examining the oral
cavity to prevent direct contact with the oral/facial tissues.
If using Vaseline, beware to keep any sources of oxygen
away as may be hazardous.
3.1.6 Patient positioning
Allow patients to position themselves in their own
time or allow parent/caregiver to position the
child in a comfortable position, as they are familiar
with how best to handle their child. Do not try to
assist them if you are not aware of the areas where
they have wounds.
Consider padding the dental chair or ask patients
to bring any pressure reduction item such as a
wipeable seat cushion, blanket or mattress topper.
Give patients breaks to rest and change position,
according to their needs.
For very small children, consider examining on
parent’s lap using the “knee to knee” technique
(Image 3.4).
Even though most patients do not express discomfort in
relation to the lesions on their back while sitting on dental
chairs,35 supplemental padding can be used during dental
treatment to prevent potential friction trauma to the skin.35
Patients should place themselves on the operating table
if possible.40 A stretcher should be padded with a wipeable
soft material, seat cushion, or mattress topper.3,41,42 Trans-
fer and position changing should be done by moving the
blanket, as patients should not slide on/across areas.42
IMAGE 3 . 4 Knee-to-knee position for examining a 3-year-old
patient
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IMAGE 3 . 5 Thirty-three-year-old patient with EB having low-
level laser therapy (LLLT) after oral surgery to reduce pain
If available, slide sheets can be used to aid patient
positioning. Ensure that all team members are aware they
need to lift and not slide the patient onto the table.
3.1.7 Oral bullae and ulcerations
Although oral bullae, ulcers, and erosions are the most
common oral feature of EB, there are only two published
studies of therapeutic approaches for these oral lesions.
In 2001, Marini and Vecchiet43 described that sucralfate
suspension reduced the development and duration of oral
mucosal blisters and ulcers, reduced the associated oral
pain, and improved plaque and gingival inflammation
indices.43 In 2017, Sindici and colleagues44 published a
pilot evaluation of the use of cord blood platelet gel (CBPG)
and low-level laser therapy (LLLT) over a 3-day treatment
period: one application daily on 19 long-standing symp-
tomatic oral lesions of seven patients with dystrophic EB.
Reported pain and clinical size of lesions improved from
the first day of treatment provided, reducing discomfort
from ulceration. During the follow-up period, only one
patient developed a new lesion in the same treatment
site; all patients continued to have other oral lesions at
untreated sites. The only adverse effect reported was the
unpleasant taste of the medication that was still reported
by two patients (28%) after 24 weeks.44
In addition to these strategies, mouthwashes and oral
gels aimed at managing mucositis and oral lesions are
commonly prescribed to patients with EB. The availabil-
ity of these mouthwashes will vary between countries, and
the clinical effectiveness will also vary among patients.
Some of the products available are: Gelclair R© (Helsinn
Healthcare SA, Switzerland), K-trix R© (calendula based;
Farpag, Colombia), and Dentoxol R© (Ingalfarma, Chile)
(Image 3.6A–C). Several patients report the use of gargling
saltwater as a cost-effective and readily available alter-
native. There is a lack of published scientific reports on
their effectiveness in EB. Randomized controlled trials are
needed to determine the best treatment strategies.
3.1.8 Preventive strategies
Partnership
A partnership approach between the family, the patient,
and the dentists is fundamental for achieving and main-
taining an adequate oral health status. The informa-
tion transmitted to parents or caregivers should take
into account their background knowledge on dental care,
socioeconomic status, educational level, and the directions
should be simple and easy to follow.45
Oral hygiene
At home
Concern is expressed by some patients, parents, and
dentists regarding the use of toothbrushes and potential
damage to the oral mucosa. Some patients find it difficult
to perform oral hygiene due to oral lesions14,46 bleeding,
blisters, limited mouth opening,45,47 and parents’ fear of
IMAGE 3 . 6 (A)-(C) Mouth washes and oral gels aimed at wound healing
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IMAGE 3 . 7 Forty-one-year-old patient with intermediate
RDEB cleaning her fixed denture with an interdental brush
causing pain.48 Studies have found that those patients who
have been instructed on oral hygiene brush with a simi-
lar frequency, but use dental floss less regularly than those
without EB.47
Even though patients might develop mitten deformities
on their hands, only few patients have raised this prob-
lem as an issue for holding a toothbrush.45 Similar dis-
parity exists with regard to the use of dental floss. Some
authors strongly advocate for its use,45 others have proven
its difficulty.35
Toothbrushing is possible in all patients with EB,
even in patients with severe RDEB. The follow-
ing suggestions can help determine the appropri-
ate toothbrush for each patient:
a. Small head.7,11,15,49
b. Soft bristle.7,11,49,50
c. The smallest toothbrush available (such as a
baby-size toothbrush35,45) should be used.
d. Bristles can be further softened by soaking
them in warm/hot water.10
e. In patientswith severemicrostomia, short bris-
tles are indicated to access occlusal surfaces of
molars. If there are no commercial short bris-
tle toothbrushes available, bristles can be cut.
If bristles are cut, one needs to ensure that they
remain soft and do not harm the tissue.
f. Parents or caregivers are advised to assist chil-
dren, to improve plaque removal and helping
to reduce the risk of tissue damage.15 Occasion-
ally, adolescents and adults will also require
support from caregivers for daily oral hygiene
to increase effectiveness in areas difficult to
reach.
g. A manual toothbrush may be preferable to an
electric brush, because of the increased possi-
bilities of generating tissue trauma or bullae.
h. Special toothbrushes, as, for example,
Collis Curve R© toothbrush, Dr. Barman’s
IMAGE 3 . 8 Examples of toothbrushes available for patients
with limited mouth opening: (A) standard toothbrush. (B) Collis
Curve baby toothbrush, (C) Collis Curve Junior Toothbrush, and (D)
Pro Super-fine (Esro AG) Toothbrush
IMAGE 3 . 9 Collis Curve™ toothbrush (Collis-Curve Tooth-
brush, TX, USA) cleans the palatal and buccal sides of the teeth
simultaneously
Superbrush R©, andOralieve 360◦ Toothbrush R©
might be good options for patients with RDEB,
but more research on its efficiency is needed
(Images 3.8 and 3.9).
i. Finger guard brushes can be used by par-
ents/carers as bristles are soft (Image 3.1).
j. Special adaptations of the toothbrush han-
dle can be advantageous for patients with
pseudosyndactyly and manual dexterity prob-
lems. An orthotic such as the Oliber R© could
be useful for patients with pseudosyndactyly
(Image 3.11).
IMAGE 3 . 1 0 Thirty-year-old patient with RDEB and pseu-
dosyndactyly performing oral hygiene with a small handle
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IMAGE 3 . 1 1 A 19-year-old patient with RDEB and complete
pseudosyndactyly performing oral hygienewith theOliber R© orthotic
IMAGE 3 . 1 2 Use of disclosing solution in a patent with RDEB
to educate on brushing technique
Rinsing with water during the day, particularly
after meals,10,51 also helps oral hygiene as it
helps remove food debris or sugar deposits par-
ticularly in patients with reduced oral function
and restricted oral clearance. Oral irrigators can
remove food debris, but low water pressure needs
to be used to avoid mucosal injury.
Disclosing solution or tablets to help identify dental
plaque are a useful tool to help patients assess their
effectiveness when brushing their teeth. They can
be used by all patients with EB (Image 3.12).45
Professional hygiene
Gentle and careful ultrasonic scaler and selective
polishing techniques can be used in all patients,
including severe RDEB.11 Hemorrhagic bullae can
appear due to vibration on themucosa. If this hap-
pens, they should be drained by piercing the bul-
lae with a sterile needle or by a cut with scissors to
avoid lesion expansion due to fluid pressure (more
detailed description in Section 3.2.1.iv).
Some clinicians prefer to use hand scaling technique to
reduce the need for suction and have a better view and con-
trol of the treatment.
Adjuvant therapies
Chlorhexidine
Chlorhexidine 0.12% has widely been advocated
for oral disease prevention in patients with
EB.7,10,11,15,17,45,51,52 It has shown to be effective for
candida while ineffective for caries control.
A variety of applicationmethods have been used, includ-
ing mouthwashes, swabs, sprays, gels, and topical varnish
applications. An example of a preventive treatment proto-
cols is a rinse two times a day for 2 weeks every 3 months.
Alcohol-free formulations are advised in patients
with oral lesions.10,11,49
Fluoride
Caregivers should begin brushing a child’s teeth
as soon as they come into the mouth. Fluoridated
toothpaste should be used with dose appropriate
to the age.
Topical applications of high-dose fluoride varnish
are suggested every 3months in patients with high
caries risk; or at each dental visit.7,15,18,35,51
For children who live in nonfluoridated commu-
nities, the importance of daily fluoride supple-
ments has been highlighted.10 Dosage should be
prescribed according to local regulations, consid-
ering age and weight.
Fluoride can also be prescribed as a foam,14 gel
preparation,45 or mouthwash. Gel preparations can be
applied with a toothbrush, in a custom made plastic tray10
or with cotton rolls. Mouthwash formulations should be
alcohol-free in patients with oral lesions. These 0.05% and
0.2% fluoridated solutions can also be applied topically
with a cotton bud on all teeth once a day.53 For patients
with sensitivity, the use of a nonflavored, nonfoaming, flu-
oridated toothpaste, as, for example, Oranurse R© (found
RIS Healthcare, Welwyn, UK) may be useful.
Apreventive fluoride regimen should consider these rec-
ommendations, together with the best international evi-
dence available on caries prevention strategies.
Dietary modifications
Nutritional requirements of patients with EB can be sig-
nificantly increased, especially in severe subtypes such
as RDEB. This regular and targeted intake of high
kcal/high protein foods is essential for growth and pre-
vention of malnutrition-related comorbidities. To meet
these high targets, dietary advice may also include the
use of high sucrose nutritional supplements, which can
be particularly cariogenic. Dietetic advice should be given
to minimize the diet’s impact on dental health while
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optimizing the patient’s nutritional status, ideally from
birth onward.
Leal and coworkers found that patients with RDEB have
a similar number of food intakes and similar sugar content
than the control group; the main difference was the food
consistency, as patients with DEB preferred soft food.47
From the patient’s perspective: “This is tricky because a
lot of kids are tiny, and just desperate to get calories, espe-
cially when they are younger and less cooperative. Many
also drink high calorie formulas, and others will have g-
tubes. (. . . ) My daughter who is 6.5 (. . . ) drinks a very high
caloriemedical formula to supplement her diet. She drinks
this with the nipples she has been using since she was in
the neonatal intensive care unit. We have never made her
stop because she needs the calories. She drinks everything
else in an age appropriate way, but I think because the for-
mula is pretty thick, she can only tolerate it in this tiny
stream. I’m sharing this because I know many other kids
withEBwhodo this. I think dentists should be aware that it
occurs, maybe even ask about it. Though I wouldn’t expect
patients to stop if it is working. . .because they will priori-
tize caloric intake.” (R.B., Los Angeles, USA)
A dietary caries-prevention program should be
instigated at an early age.17,50
It is essential that dentists and dieti-
tians/nutritionists collaborate on an appropriate
program for each patient, as opposed to giving
contradictory advice that may confuse patients
and parents/guardians.
Fissure sealants and other aids
Sealing fissures and fossae has been recommended,
as oral hygiene and other preventivemeasures can
be difficult to perform.10,18,45,54
IMAGE 3 . 1 3 Fissure sealing in a lower second molar of a 16-
year-old patient with RDEB
IMAGE 3 . 14 Caries arrest from SDF (note black stain of the
teeth) in 6-year-old patients with severe RDEB and severe early child-
hood caries (ECCs)
When moisture control is challenging due to lim-
ited cooperation, compromised access, and diffi-
cult long-term follow-up, glass ionomer can be
used as an alternative to resin-based sealing mate-
rials.
Other remineralization techniques, such as silver
diamine fluoride (SDF) can be used for the non-
invasive management of caries lesions in patients
with EB (Image 3.14).
Xylitol-containing chewing gum can be used as
a preventive strategy for those patients with a
high risk of caries. There have been reports where
either xylitol chewing gum, or mints have been
used in EB patients with no adverse mucosal
effects.35
3.1.9 Microstomia
Limited mouth opening has been reported as the great-
est clinical difficulty for providing dental treatment
(Image 3.15)55,56 as well as complicating intubation.57 In
IMAGE 3 . 1 5 Microstomia makes access to the oral cavity dif-
ficult
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IMAGE 3 . 1 6 Adult with Kindler EB performing mouth open-
ing exercises with a commercial device: TheraBite R© (Atos Medical,
Malmö, Sweden)
this context, the consulted literature provides no definitive
solutions. Slight increments in the maximum oral aper-
ture have been obtainedwithmechanical techniques. Four
techniques have been described (Images 3.16 and 3.17).
The first technique uses resin plugs of progressively
increasing caliber. The patient increased his maximal
mouth opening from 19 to 23 mm after 10 minutes of exer-
cise, and to 30 mm at the end of a treatment session.54
Unfortunately, this parameter returned to the initial values
on discontinuing mechanical therapy. Other suggestions
include daily exercises with wooden spatulas,58 mouth
trainer, and threaded acrylic cone (Images 3.16 and 3.17).
A surgical approach to improve microstomia has also
been reported, aimed at releasing the scar bands at the
commissures and buccal mucosa.59–61 More research is
needed to confirm the long-term effectiveness of this pro-
cedure.
Patients with severe generalized RDEB should per-
form daily exercises to improve/maintain a good
mouth opening. This can be performed, for exam-
ple, during dressing changes.
Performing exercises half an hour before dental
treatment helps improve access.55
Improving mouth opening also favors speech and
swallowing.
A surgery to release the buccal intraoral scar bands
can aid mouth opening.
3.1.10 Prescriptions
When prescribing medications for patients with
RDEB, it is important to consider that swallow-
ing could be difficult due to esophageal steno-
sis/strictures or could cause esophageal trauma.
Therefore, medications should be in soluble or liq-
uid form. If sugar-free preparations are not avail-
able, parents should be advised of the sugar con-
tent and advised ideally to brush or at least rinse
the child’s teeth with water directly after admin-
istration of the medication to reduce the risk of
decay.
3.1.11 Review appointments
Frequent recall visits have shown to be useful to main-
tain dental health in patients with EB.15,16,62 There are
examples of patients who previously had extensive carious
teeth who remained caries free when attending frequent
review appointments.15,62 On the other hand, clinical cases
have been reported, showing that patients who failed to
attend the review visits developed several caries within 2
years, despite a preventive program being explained.11,17
Moreover, in some patients, even the advice and follow-up
appointments are not enough to avoid the development of
dental caries.47
IMAGE 3 . 17 Custom and homemade appliances to perform mouth opening exercises. (A) and (B) Acrylic cones, (C) wooden spatulas,
(D) and (E) mouth trainer, and (F) clothes peg to gently exercise opening
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As many patients have to travel long distances, review
appointments should be scheduled together with other
health care appointments. A shared care approach can be
considered.
Frequency of dental review should be sched-
uled on an individual basis according to the
amount of plaque present and risk of caries.
Every 3 to 6 months may be sufficient for some
patients, for others monthly appointments may be
necessary.5,7,14,16,35,45,48,54,63
As the predisposition to develop intraoral SCC
increases with age, cancer screening must be con-
sidered a very important aspect of the review
appointment in patientswithRDEB from the third
decade and in patients with Kindler EB from
the forth decade, regardless of the presence of
teeth.24,28–34,51
Any unusual ulcer or persistent white or red lesion
should be biopsied to ensure that these do not
represent precancerous or cancerous lesion in the
mouth.1
Monitoring with clinical photographs should also
be considered.
To summarize, the review sessions should be aimed at:
a. Caries prevention/early diagnosis
b. Professional plaque removal
c. Topical fluoride application
d. Dietary advice
e. Review progress or deterioration of patient’s oral condi-
tion
f. Cancer screening
3.2 Dental treatment for patients
with Inherited Epidermolysis Bullosa
3.2.1 Treatment
modifications—Precautions
Even though patients with mild oral involvement do not
require many treatment modifications, a careful approach
benefits every patient. Patients with the generalized forms
of RDEB require the most specific precautions during
treatment to minimize soft tissue damage.
i. EB simplex (EBS)
Clinicians should ask about history of mucosal fragility
since manipulation can precipitate lesions in mildly
affected patients.7 Although this has not happened to the
members of the panel; it is recognized that EB is very
diverse and that it could happen. Patients with general-
ized types of EBS can have difficulties, for example, tol-
IMAGE 3 . 1 8 Blister on the tongue of a patient with EBS due to
plectin mutation
erating the suction tip, as well as other dental procedures
(Image 3.18).
Most authors agree that routine dental treatment
can be provided.7,54,64
ii. Junctional EB (JEB)
Mucosal and skin fragility varies considerably between
subtypes of JEB and patients. The avoidance of adhesive
contact with the skin and careful manipulation is always
advised (Image 3.19). Following the suggestions listed in
section Recessive DEB can be of help for these patients as
well.
This group of patients will require a special dental reha-
bilitation plan, as they present with generalized enamel
hypoplasia (Image 3.20).
Mucosal management does not require many
modifications;6 however, a careful approach is
advised as tissue manipulation can produce oral
ulceration.
This group requires an aggressive preventive
program and frequent visits to the dentist as
they present with generalized enamel hypoplasia
(enamel defects on all their teeth), leading to an
increased risk of cavities and severe attrition.
If tooth sensitivity is severe or aesthetic considerations
are causing behavioral issues, dental rehabilitation should
include crowns or veneers from an early age.
IMAGE 3 . 1 9 Two-year-old patient with JEB and perioral gran-
ulation tissue
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IMAGE 3 . 2 0 Five-year-old patient with JEB: generalized
enamel hypoplasia. Perioral granulation tissue has healed without
scarring
A periodontist should be included in the multidis-
ciplinary care of patients with JEB if they present
gingival overgrowth needing gingivectomy.
iii. Dominant DEB (DDEB)
Patients withDDEB are able to receive routine den-
tal treatment with little or no modifications.6,24
Nevertheless, a careful approach is still advised as
tissue manipulation can produce oral ulceration.
iv. Recessive DEB (RDEB)
Patients with the severe and the intermediate subtypes of
RDEB require several treatment modifications and a care-
ful approach to avoid as much tissue damage as possible.
It has been described that on prolonged contact with den-
tal instruments, the epithelium can be sloughed off, expos-
ing areas of erythema.35 Management of these patients
ideally requires a well-organized multidisciplinary team
approach,14,37,41,48,63 with good communication involving
case discussion.
1. Lubrication
Lips should always be lubricated with petrolatum,
Vaseline R© (Unilever), Linovera R© (B.Braun),
or other appropriate lubricants or emollients
before any procedure is performed to reduce
adherence and shearing forces that could lead
to tissues separation and lesions formation
(Image 3.21).3,7,35,45,50,63,65
There have been reports suggesting the lubrication of all
the instruments. The panel of experts recommends lubri-
cating mainly the back of the intraoral mirror, because it
has direct contact with the oral mucosa.
2. Suction tip
Bullae formation or epithelial sloughing can occur
upon contact with the suction tip.3 It is suggested
to lean the suction tip or saliva ejector upon hard
IMAGE 3 . 2 1 Lips well lubricated with Linovera R© during den-
tal treatment in a 9-year-old patient with RDEB
IMAGE 3 . 2 2 Suction tip leaned on tooth surface to avoid
mucosal sloughing
tissue, ie, on occlusal tooth surface or on awet cot-
ton roll.66
Avoid use of high vacuum suction as this could
cause sloughing of extensive areas of tissue.
3. Bullae
Blood or fluid-filled bullae that occur during treat-
ment should be lanced and drained with a ster-
ile needle or by a cut with scissors to avoid lesion
expansion due to fluid pressure.38,39,54,55,67 The
incision should be made at the lowest point of
the bullae to allow gravitational drainage allowing
the tissue to remain covering the underlying tissue
(Images 3.23, 4.9 and 5.2).
IMAGE 3 . 2 3 Fluid-filled bulla that arose on the lower lip of
a 33-year-old patient during dental treatment. It should be drained
immediately
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IMAGE 3 . 2 4 Nonadhesive foam dressing protecting the con-
tact areas
The overlying skin (roof of the blister) should never be
removed as it acts like a natural dressing and aids heal-
ing, reducing pain, and minimizing the risk of exogenous
infection.39
As observed in Image 3.35, mucosal sloughing might
happen even when all the precautions are followed. Some
patients feel that it is of benefit to reposition the broken
mucosa, as this reduces the healing time and discomfort.
4. Pressure
Extreme care of fragile tissues is important. To han-
dle tissues, a little pressure (compressive forces)
can be applied, but no sliding movements (lateral
traction or other shear forces) should be used, as
these can cause tissue sloughing.7,11,55
Patients might prefer to have their extraoral
areas covered with nonadherent wound dress-
ings, as, for example, Mepilex Transfer R© (Mölnly-
cke, Gothenburg, Sweden) to reduce the shearing
forces and wounds on the lips (Image 3.24).
5. Air-water syringe
Occasionally, when using the air syringe to dry the teeth
during a dental examination or treatment, an air-filled
bulla can occur. If this happens, they have to be drained.
Air syringe can be used, but should be managed
carefully.11
6. Instruments
Due to limited access, it is easier to use pediatric
size instruments.1
A laryngeal mirror can also be helpful in patients
with severe microstomia. Flat malleable retrac-
tors are useful for separating the cheeks, as they
spread force over larger area and can protect tissue
IMAGE 3 . 2 5 Lip wound caused by the removal of a cotton roll
that was not lubricated or soaked with water
if having to prepare a tooth for restorative treat-
ment. They come in various widths and are typi-
cally available in hospital operating rooms.
7. Isolation
Relative isolation:
• Dry cotton rolls stick to the mucosa and can
damage the mucosa during removal (Image 3.25).
To avoid mucosal damage, cotton rolls can be
lubricated with water soluble lubricants such as
surgilube R© (Novartis, Switzerland) before placing
them inside the mouth. When removing them,
they must be soaked with water.
• Consider reducing the size of the cotton rolls so
they can fit in limited spaces. This might be done
by splitting cotton rolls in half to fit in the obliter-
ated vestibules.35
Complete isolation:
• Rubber dam can be retained using clamps,
but also aided with wooden wedges or Wedjets R©
(Coltene, Altstätten Switzerland) dental dam sta-
bilizing cord. If choosing clamps, they have to be
placed with caution as their placement and posi-
tioning could cause blisters or wounds on the lips
and cheeks.
• The back of the rubber dam can be lubri-
cated to reduce friction with the oral mucosa.
Alternatively, a rubber dam napkin can be used
(Image 3.26).
Even though these recommendations aid in the place-
ment of a rubber dam to achieve complete tooth isola-
tion, sometimes, it is not possible due to limited mouth
opening35 or the patient’s anxiety.18
45
IMAGE 3 . 2 6 A rubber dam napkin
8. Visual access
In severemicrostomia, it is easier to separate the lip
using the handle of the mirror instead of the mir-
ror itself, or flat malleable retractors as explained
before.
When possible, consider use of head light.
9. End of session
At the end of every clinical session, it is impor-
tant to check for fluid-filled or blood-filled bul-
lae and drain them. As explained previously, over-
lying skin should never be removed and mucosa
or skin that slough-off during treatment should
be repositioned. It is also important to check and
remove any remnants of dental materials in the
sublingual space or vestibule, as the patients have
ankyloglossia (tongue fused to floor ofmouth) and
cannot clear the mouth easily. This can be done
with a wet cotton roll.
v. Kindler EB (KEB)
A careful approach is advised, as mucosal slough-
ing can occur following dental treatment such as
scaling.68
Periodontal health is the main area of concern
for dental therapy as there is a higher preva-
lence, earlier onset, and faster progression of
periodontitis.69 Scaling, root planning, and regu-
lar dental care are important factors. Regular den-
tal visits are a very important factor to control ero-
sive gingivitis and aggressive periodontitis.70
3.2.2 Dental radiography
In most patients with EBS, JEB, DDEB, localized
RDEB, and Kindler EB, all diagnostic techniques
can be used with no or little technique modifica-
tion.
IMAGE 3 . 2 7 Orthopantomography of a 10-year-old patient
with severe RDEB
In patients with severe and intermediate form
of RDEB routine, periapical technique has been
proven to be extremely difficult especially in
the posterior area due to microstomia, anky-
loglossia, and scarring of the sublingual area.
Orthopantomography (panoramic radiograph) is
the technique of choice.1
Other diagnostic techniques that could be consid-
ered include:
∙ Bitewings using small films.
∙ Covering the edge of the film with soft periph-
ery wax.
∙ Some digital panoramic radiographs have
extraoral bitewings capabilities making them a
good option for patients with limited access.
∙ Use of cone beam radiography can target certain
areas without tissue damage.
∙ For digital sensors, sharp edges should be
avoided. The sleeve should not have any sharp
edges. As an alternative, the finger of a glove can
be used.
∙ Occlusal technique can also be used for anterior
teeth14 or lateral oblique for mandibular poste-
rior teeth.
If periapical radiographs are required in RDEB,
care must be taken not to damage the mucosa.11
Lubrication of the film packet has been advised to
avoid tissue damage.71
3.2.3 Restorations
Restorative treatment can be difficult in patients with
RDEB due to microstomia, soft-tissue fragility, vestibular
obliteration, and complex anesthetic management.72
Caries removal: Some authors prefer to remove car-
ious tissue manually and with low-speed round
burs.14
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The use of small-sized instruments, short-shaft
dental burs, and hand pieces with a small-sized
head are indicated.45 Swing oscillating handpieces
can also aid to reach difficult angles.
There are no contraindications to the use of con-
ventional dental materials.7,73
The restorative material to be used will depend on
the possibility of achieving isolation, caries risk,
and cultural and economic factors.
Consider minimally invasive dentistry (MID) tech-
niques, such as SDF or atraumatic restorative
technique (ART).18,74
The use of stainless steel crowns should be
considered.7,54
Restorations and dentures should be carefully
adapted and highly polished to lessen the risk of
iatrogenic oral mucosal blisters and ulcers.50
Iatrogenic blisters can develop after treatment even
if all precautions are in place.54
Soft tissue lesions resulting from restorative treat-
ment typically heal in 1 to 2 weeks and require no
specific treatment.66
If required, analgesics can be prescribed.
3.2.4 Endodontics
Root canal (endodontic) treatment (RCT) can be
performed in all patients, unless there is no access
due to microstomia (limited mouth opening).66
In patients with severe microstomia access to the
pulp chamber might need to be modified. For
example, anterior teeth might need buccal access.
For determining root canal working length in
patients with RDEB and severe microstomia, it
is best to use electronic apex locator14,18 or, if
unavailable, a panoramic radiograph (as periapi-
cal radiographs are difficult to take). Cone beam
computed tomography (CBCT) may be useful to
determine working length prior to endodontic
treatment.
Rotary instruments used with small-head end-
odontic motors have an advantage if there is lim-
ited working space. Short files (21 mm) as well as
some occlusal reduction of the cusps can allow
RCT even in cases where otherwise treatment
would not be possible due to lack of space.
Concern has been raised regarding the safety of
using sodium hypochlorite for root canal decon-
tamination when isolation is challenging due to
difficulties inmaintaining the rubber dam in posi-
tion due to the lack of vestibule and space for the
clamp. Gingival barrier can be used to facilitate
single tooth isolation. (See section RDEB Isolation
technique.)
3.2.5 Impression taking
Concern has been raised by dentists and patients regard-
ing the safety of taking impressions in patients with frag-
ile mucosa. No adverse events (ie, mucosal damage) have
been published. The main challenge is microstomia, as
impression trays might not fit into the mouth.
Impressions should be taken with special care in
RDEB.66,75,76
All type of impression material can be used.
Microstomia can be a real challenge. As an alter-
native to stock impression trays, custom-made
acrylic trays or specially cut topical gel application
trays have been proposed50,77 (Images 3.28, 3.29,
and 3.30).
A suggestion for designing the custom-made tray is to
take a first impression with high-viscosity silicone putty
and to construct the custom-made tray on a second step.
Alternatively, silicone putty can act as a custom-made tray
with low-viscosity silicone to capture the details of the
preparation (Image 3.31).
IMAGE 3 . 2 8 Impression using silicone and a custom-made
tray in a 36-year-old patient with severe RDEB
IMAGE 3 . 2 9 Stock tray and custom-made acrylic tray (size
comparison)
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IMAGE 3 . 3 0 Sectioned individual impression tray
IMAGE 3 . 3 1 Impression using the silicone putty as a tray
It is very important not to introduce too much silicone
into the oral cavity, since in the polymerized state, it can be
difficult to remove.
If the cervical margin is subgingival, a gingivec-
tomymay be needed. For information on this mat-
ter, consult the gingivectomy section.
Intraoral scanners can be a noninvasive harmless
impression solution for oral rehabilitation, such as
surgical and prosthodontic implant planning and
placement in RDEB.56
Stereolithographic models can be used as a diag-
nostic aid.
3.2.6 Oral rehabilitation
Oral rehabilitation can be fixed or removable depending on
the health system and financial possibilities.
Whenever possible, fixed rehabilitation is
advised.48
Fixed rehabilitation
Successful oral rehabilitation with fixed bridges
has been reported in several patients with
severe RDEB;11,50 improving aesthetics, oral
function, and enhancing patients’ confidence
(Image 3.32).50
IMAGE 3 . 3 2 The smile of a 30-year-old patient with severe
RDEB and severe microsomia before and after fixed crown oral reha-
bilitation
In patients with generalized enamel hypopla-
sia, restoration of the entire dentition with full
crowns may be necessary. This treatment has to
be planned carefully and discussed with the par-
ents and the patient, as it may consist of sev-
eral stages until full permanent dentition has been
established and restored (Image 3.33).67,78
The use of stainless steel crowns has been reported
as a successful approach in children with RDEB
and JEB6,7,54,79 (Image 3.34).
An anecdotal fixed denture in a 3-year-old child
with EBS to replace the anterior teeth without
causing irritation on the mucosa was reported
by Chuang.48 The maxillary growth needs to be
carefully followed up in this type of rehabilita-
tions.
Removable dentures
The tolerance to bear tissue-supported dentures depends
on the degree of mucosal fragility of each EB subtype and
patient.
Reports of patients successfully tolerating remov-
able dentures include patients with EBS, JEB,
DDEB, and pretibial RDEB.6,54,80,81
In selected cases, patientswith generalized forms of
RDEB can use dentures if the flanges are adapted
and the clasps are flat and do not irritate the
opposing mucosa.
Overdentures have been described as a practi-
cal, economic, nonsurgical treatment option for
patients with JEB and generalized hypoplastic
enamel who present with failure of eruption.80
48
A B C
IMAGE 3 . 3 3 A 9-year-old boy with junctional EB and generalized hypoplastic enamel being treated with gingivectomy and complete
oral rehabilitation of the hypoplastic teeth in one session under sedation. (A) Before treatment (upper right central incisor has a temporary
restoration), (B) first stage of treatment: gingivectomy, and (C) 1 week after the clinical session: all incisors are crowned
IMAGE 3 . 3 4 Stainless steel crowns on a 6-year-old boy with
junctional EB and generalized hypoplastic enamel
Careful follow-up is needed due to the high risk
of caries.
Implant rehabilitation
As this is an area of high interest for patients and clinicians,
a new chapter on this topic has been dedicated to den-
tal implants: Chapter 4: dental implants in patients with
recessive dystrophic EB - clinical practice guidelines.
3.2.7 Periodontal treatment
Periodontal treatment can be performed in all
patients with EB. Special care must be taken in
patients with RDEB, as there might be substantial
bleeding during the procedure.11,66 Some authors
prefer to use hand scalers.35
Gingivectomy can be performed with laser or
scalpel. Patients with Kindler EB may need this
technique to remove hyperplastic gingival papillae
and patients with JEB to manage gingival hyper-
plasia (Image 3.33B).
3.2.8 Oral surgery
Suturing
There has been debate in the literature about the fea-
sibility of suturing after oral surgery in patients with
EB.9,15,55,63,79,82
Sutures can be used safely in all patients with EB
but need careful placement and might not always
be possible due to the mucosal fragility.
Vestibuloplasty
Severe obliteration of the oral vestibule due to scarring can
cause difficulties in eating,59 performing oral hygiene,59
providing dental treatment, and reducing food clearance
due to reduced mobility.
Periodontal plastic surgery and vestibuloplasty to
deepen the vestibule or to restore the alveolar
ridge height has been reported in two patients
with dominant dystrophic EB (DDEB).59,60 The
panel has limited but positive experience on this
surgery in patients with RDEB. This surgery is rec-
ommended when required, ie, when the oblitera-
tion affects the patient’s quality of life or oral func-
tion.
Inserting a soft acrylic stent extending to the newly
established vestibule avoids fusion of the connec-
tive tissue layers and allows time for epithelium
migration on both surfaces.60
Alternatively, a periodontal dressing, such as Coe-
Pak R© (GC, Tokyo, Japan), can be placed between
the alveolar ridge and the lips to avoid fusion dur-
ing the healing period/during the first days after
the surgery.
Oral commissures release
Only few cases of surgical release of oral commis-
sures scarring have been reported, with limited
details on the long-term success.83
Biopsy
Biopsies of oral tissues may be required when oral
squamous cell carcinoma (OSCC) is suspected.
(See Section 3.1.11)
Surgical extractions
Contemporary oral health care is targeted at prevention
of oral disease, but some patients still require extractions
due to severe caries or the need for orthodontic care
that involves severe dental crowding. Surgical/difficult
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extractions should be performed by an experienced dental
provider.
When planning surgical extractions, especially if
multiple extractions are needed, it is advisable to
consult the patient’s physician as profound ane-
mia could complicate the dental surgery.41
For multiple extractions, it has been suggested to
extract first the anterior teeth (ie, from premolar
to premolar) and then the molars to allow optimal
access.41
An atraumatic technique should be used, making
firm and safe mucosal incisions to prevent bullae
formation.10,55
Hemostasis can be achieved with gentle pressure
using gauze packs.9,79 These should be wet to
avoid tissue adherence. Other hemostatic agents,
such as collagen sponges, gelatin sponges and oxi-
dized cellulose can be used safely.
Wound healing process of extraction sockets in
patients with this condition remains unaltered. Some
authors have reported the extraction of healthy third or
even second permanent molars in patients with severe
RDEB to improve or facilitate oral hygiene.4,84 There is
controversy among different authors about this inter-
vention. Severe tooth crowding,12,54,85 reduced alveolar
arches secondary to growth retardation,49,86 and severe
microstomia3,15,54,55,82,87–89 are described in patients with
generalized severe RDEB, which would justify preventive
extractions. However, nowadays most patients receive
dietetic advice that optimizes nutrition and growth. They
receive orthodontic treatment (serial extractions) and are
advised on exercises to improve microstomia. Therefore,
preventive extractions of permanent molars need to be
assessed very carefully on an individual basis.
Perioperative complications. Despite attempts to use as
gentlemanipulation as possible and follow the precautions
described above, mucosal sloughing and blister formation
has been reported after almost every surgical extraction in
patients with severe RDEB (Image 3.35).3,9,41,54,79 Blisters
can arise at the angles of themouth, lips, vestibule, tongue,
and any sites of manipulation; some measuring up to 4 cm
× 3 cm.3,41 In some instances, they might only be noticed
by the patient or carer only on the second postoperative
day.9 As described in Section 3.2.1, tissue that has sloughed
off should ideally be repositioned. If this is not possible, it
should either be left of cut with scissors, but never torn, as
this would increase the size of the wound.
Postoperative complications. Despite the potential for
extensive mucosal damage during surgery, postoperative
complications are rare.9,41,90 Healing of the oral tissues
occurs gradually after 1 to 2 weeks.17,53,79 Healing of the
IMAGE 3 . 3 5 Bullae, ulcers, and mucosal sloughing after sur-
gical extractions
alveolar sockets seems to be uneventful.9,62 Nevertheless,
scarring of the oral commissure or wounded areas can be
accentuated after surgery.3,9 The patient should be advised
to perform mouth opening, lip, and tongue movement
exercises during the healing process to maintain oral
functioning.
The use of postoperative antibiotics will depend on each
individual case, and there is no particular need because of
the patient’s EB condition.
Osseointegrated implants. As osseointegrated implants are
an area of growing interest for people with EB and their
clinicians, a separate “Guideline on Dental Implants in
Patients with Recessive Dystrophic Epidermolysis Bullosa”
has been developed. Only key elements are presented.
Successful rehabilitation using dental implants has been
reported in patients with generalized RDEB, intermediate
JEB, and inversa-RDEB.7,55,65,87 One-year osseointegration
success rate, based on 217 implants, is 98.6%. Peri-implant
mucosa remained in good condition in all patients.8,56,65
It has been reported that after rehabilitation, patients
improved their ability to chew, swallow, and their quality
of life.55,65,75,76
Sialolithiasis of submandibular gland. Successful surgical
removal of a sialolith using local anesthesia has been
reported once. The intervention was extremely challeng-
ing due to the patients microstomia and ankyloglossia.36
Another patient who has had the same issues reported suc-
cessful stone dislodgment after sucking lemon to increase
salivary flow.
3.2.9 Orthodontics
In patientswith less severemucosal fragility and oral
scars (EBS, JEB, DDEB, KEB):
∙ Orthodontic treatment only requires minor
modifications.7 Patients with generalized and severe
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IMAGE 3 . 3 6 Eleven-year-old patient with severe RDEB. Serial
extractions of the first upper premolars were planned to allow erup-
tion of the canines
forms of EBS and JEB, however, can have more mucosal
fragility requiring the precautions indicated below.
In patients with severe mucosal fragility and oral
scars (RDEB):
Serial extractions are strongly recommended in patients
with severe RDEB to prevent dental crowding, as this con-
tributes to high caries risk and periodontal disease.
a. The aim of orthodontics in severe RDEB should be to
avoid tooth crowding and obtain tooth alignment.
b. Serial extractions should be performed at the appropri-
ate stage of dental development (Image 3.36).
c. A risk-benefit analysis should be performed on an indi-
vidual basis to avoid the need for repeated general anes-
thetic for serial extractions. These procedures should
ideally be done with behavioral support techniques and
local anesthesia.
d. When using fixed orthodontic appliances, microsto-
mia and vestibule obliteration might affect the treat-
ment plan. Most patients tolerate braces surprisingly
well, although small modifications such as removing
the hooks might be necessary (Image 3.37). Placement
and bonding of posterior brackets might be challenging
and not possible in all patients.
To prevent lesions on the soft tissues orthodontic
wax/relief wax can be applied on the brackets.84
Even though some authors have stated that orthodontic
treatment can only be performed in mild forms of EB,77
fixed orthodontics have successfully been able to achieve
tooth movement in order to: (a) correct a one tooth cross
bite, (b) close diastema, and (c) align the anterior teeth in
patients with severe RDEB.
A tooth-borne removable appliances and clear aligners
may also be possible treatment options.
Images
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Introduction
Children and adults living with recessive dystrophic EB
(RDEB) present severe skin fragility. The oral mucosa is
extremely friable and may slough off easily when touched.
Patients present generalized blistering that may be fluid-
or blood-filled and arise at any oral mucosal surface, espe-
cially the tongue. Due to scarring, patients will present
ankyloglossia and absence of tongue papillae and palatal
rugae. The labial and buccal vestibules present severe
obliteration, compromising oral hygiene procedures, den-
tal treatment, and the wearing of removable prosthetic
appliances. Progressive microstomia remains as one of the
main challenges, as it gives rise to a wide variety of func-
tional problems that include difficulties in eating, speech,
and oral hygiene maintenance.1–13 Although the approach
to dental treatment is focused on prevention and behav-
ioral support, dental disease can be difficult to control, and
patients may lose several teeth or even become edentulous
and will need oral rehabilitation to improve their function
and aesthetics.11
DEBRA International (DI) is the worldwide network of
national groups working on behalf of those living with
EB. As part of their vision to work toward ensuring access
to the best quality support and medical care for peo-
ple living with EB, DI entrusts the development of clini-
cal practice guidelines (CPGs) to health care profession-
als with significant experience in EB. The first CPG on
oral care was published in 2012.11 Since then, new scien-
tific literature has become available and it has become
necessary to update the guideline. As dental implants
have become an increasing area of interest, with multi-
ple high-quality reviews in the recent years,14–18 the guide-
line development panel has considered it appropriate to
add a new chapter on dental implants in RDEB. The
present CPG on dental implants for patients with RDEB
has been developed by an international panel, using a
standard methodology based on a systematic review of
the currently available scientific evidence and consensus
meeting.
Aim
To provide the users with information on the current best
practices on dental implant-based oral rehabilitation for
patients with RDEB.
Users
Specialists in Implantology, Oral Surgery, Rehabilitation,
Oral andMaxillofacial Surgery, Special Care Dentistry and
Periodontology.
The development panel recognizes that this CPG will
provide information for dentists and specialists in the field
of oral rehabilitation on the special approach needed for
patients with RDEB. This is not a guideline for dentists
to learn how to place dental implants. It can be used by
patients and other health care providers to be aware of the
challenges and precautions of implants in RDEB and to
make evidence-based decisions, but it will not enable them
to perform the procedures.
Target group
These guidelines can be applied to all patients diagnosed
with RDEB.
Methodology
Question definition
A meeting was held to define the questions to be
addressed in the guideline. The selected questions are:
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4.1 General information
1. What is the success rate of placing dental implants in
patients with RDEB?
2. What are the benefits and advantages in quality of life
for patients with RDEB after rehabilitation with dental
implants?
3. Which are the benefits of a fixed implant-supported
denture compared to a removable implant retained den-
ture in patients with RDEB?
4. Which are the main challenges of placing implants in
patients with RDEB?
5. Does osteoporosis affect dental implant osseointegra-
tion in patients with RDEB?
6. Which preoperative tests are needed when planning
dental implants in patients with RDEB?
7. What is the best time frame between dental extractions
and implant placement in patients with RDEB?
8. What are the special precautions that need to be taken
when handling fragile skin and mucosa during oral
surgery in patients with RDEB?
9. Would implants reduce the functional space between
upper and lower arch thus limiting the space to eat?
4.2 Prescriptions
10. What antibiotic prescription should be considered
when planning a dental implant surgery in patients
with RDEB?
11. What analgesia, anxiety, and pain management strate-
gies should be considered when planning a dental
implant surgery in patients with RDEB?
4.3 Implant surgery
12. Which special considerations need to be taken during
the incisionwhenperforming a dental implant surgery
in patients with RDEB?
13. Which types of implants have been used successfully
in patients with RDEB?
14. Which surgical technique should be used for placing
dental implants in the upper maxilla of patients with
RDEB?
15. Which surgical technique should be used for plac-
ing dental implants in the mandible of patients with
RDEB?
16. Which type of bone grafting should be used during
implant surgery in patients with RDEB?
17. Which type of interim denture has been used success-
fully in patients with RDEB?
18. Should implants be left to heal submerged or exposed?
19. Which type of suture can be safely used in patients
with RDEB?
20. What special postoperative instructions need to be
considered after implant surgery in patients with
RDEB?
4.4 Implant rehabilitation
21. What is the best time for loading dental implants in
patients with RDEB?
22. Which types of prostheses have been used successfully
in patients with RDEB?
4.5 Follow-up
23. Which complications have been reported during or
after implant supported rehabilitation in patients with
RDEB?
24. What is the best frequency of maintenance recall
appointments after implant supported rehabilitation
in patients with RDEB?
Systematic literature searching
Literature sources. The literature search ranged from 1970
to August 2018. Consulted sources included the electronic
databases MEDLINE (1970 to August 2018), EMBASE
(1980 to August 2018), The Cochrane Library (2018),
DARE (2018), and the Cochrane controlled trials reg-
ister (CENTRAL) (2018). In addition, hand-searching
journals, reviewing conference proceedings and other
guidelines sources such as The US National Guideline
Clearinghouse andTheGermanGuidelinesClearinghouse
were carried out.
Dissertations, conference proceedings, technical
reports, and other unpublished documents that meet the
selection criteria were also included. The reference lists of
all papers for relevant citations were reviewed. When all
the relevant studies were identified, they were sent to the
experts to review for completeness.
Selection criteria of the articles
Primary or secondary articles in which the main topics are
dental implants in patients with RDEB, published between
1970 and 2018 in any language, including case reports and
case series. It was desirable for the reports to have the
EB diagnoses confirmed by IFM or genetic testing; how-
ever, this was largely unavailable and could not be used
as a selection criterion. The criteria used to reject arti-
cles at first-stage screening (based on title and abstract)
and second-stage screening (based on a review of the full
text) were: (a) The article does not relate to inherited EB.
(b) The article describes dental treatment in patients with
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F IGURE 4 . 1 Method used for formulating the recommendations as described on the 50 Guideline Developer’s Handbook, NHS Scottish
Intercollegiate Guidelines Network SIGN. Revised edition January 200819
inherited EB, but does not consider dental implants. (c)
Cohort already published in previous articles. (d) Litera-
ture review which provides no new clinical information.
Search strategy
To identify studies for this review, detailed search strate-
gies were developed for each database. These were based
on the search strategy developed forMEDLINE but revised
appropriately for each database.
The search strategy used a combination of controlled
vocabulary and free text terms based on:
#1 (Epidermolysis Bullosa):ti, ab, kw
#2 (Acantholysis Bullosa):ti, ab, kw
#3MeSH descriptor Epidermolysis Bullosa explode all
trees
#4 MeSH descriptor Dental Implants explode all trees
#5 MeSH descriptor Dental Implants, Single-Tooth
explode all trees
#6 MeSH descriptor Immediate Dental Implant Load-
ing explode all trees
#7 (dental):ti, ab, kw
#8 (tooth):ti, ab, kw
#9 (teeth):ti, ab, kw
#10 (implant):ti, ab, kw
#11 (Osseointegration):ti, ab, kw
#12 (Implantation):ti, ab, kw
#13 #1 OR (#2 OR (#3))
#14 #4 OR(#5 OR(#6))
#15 #7 OR(#8 OR(#9))
#16 #10 OR(#11 OR(#12))
#17 #15 AND #16
#18 #14 OR #17
#19 #13 AND #18
Method used for formulating the recommendation
To formulate the recommendations, from the selected
studies, the SIGN Guidelines were used.
Clinical experts and patient representatives
The information from the selected studies was gathered
in evidence tables. These were analyzed and discussed
by a panel consisting of clinical leads, clinical experts,
patient representatives, and methodologists as described
in Tables 1-4 (see pages 2-4). The panel meeting was held
in Dubai on August 30th, 2018. In April 2019, a new
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literature search was performed to identify any new evi-
dence available. The panel report was reviewed by three
external specialists and a member of the multidisciplinary
EB team, as well as five patient groups (Tables 3 and 5,
pages 3 and 4). The final version was piloted in two cen-
ters in different countries for three months (September
2019 to December 2019) as described in Table 6, page
4. Patients and their representatives reviewed the docu-
ment to make sure that the degree to which the evidence
addresses patients’ concerns is reflected in the guideline.
Guideline implementation and monitoring
Implementation barriers
According to the context of implementation of this
guideline, some barriers to be considered are:
▪ Lack of knowledge and training of some health profes-
sionals to implement the recommendations.
▪ Lack of patient’s adherence to the recommendations.
▪ Insufficient provision of health services in some parts of
the world.
Guideline monitoring and/or auditing criteria
The implementation of these recommendations could be
monitored and evaluated through audits and completing
of the “CPG Evaluation Form: Pre implementation” (avail-
able at: https://surveyhero.com/c/aabc0100). The panel
recommends clinical sites to conduct prepractice audit,
implement the CPG, and reaudit to test improvements.
Audit tools can be used from SIGN35. DI would value your
feedback on the site findings to continue to improve CPG
quality.
Further areas of research.
∙ To evaluate the impact of dental implant rehabilitation
on oral functioning.
Guideline updating procedure
The guideline will be updated every 5 years after its first
version. If new relevant evidence is detected before the
update, the information will be published on the web site
http://www.debra-international.org/.
The team in charge of this update will be formed by Dr.
Susanne Krämer and Dr. David Peñarrocha in 2025.
Results
Literature search
The search strategy identified 23 articles. Eight were
original articles on dental implants in EB, three were
literature reviews, nine articles were repeated on dif-
ferent databases, and three articles were about EB
but did not consider dental implants. Cross-referencing
allowed identifying other six additional articles on den-
tal implants in EB. Only original articles on implants in
EB were included in the tables of evidence. Review arti-
cles, repeated reports, and articles on other topics were
excluded.
4.1 General information on implants
in RDEB (questions 1 to 9)
1. What is the success rate of placing dental implants
in patients with RDEB?
Summary
The literature available up to April 2019 reports implant-
based oral rehabilitation of 35 patients with RDEB, with
a total of 222 dental implants. The osseointegration suc-
cess rate after 1 year follow-up (based on 217 implants) was
98.6%. Out of this group, 110 implants were followed for 3
years, with a success rate of 100%. The 5-year success rate
based on 40 implants is also 100%. The average oral rehabil-
itation success rate was 98%. The two patients who experi-
enced fracture of their dental prosthesis had them success-
fully repaired.
Level of evidence
∙ Nonanalytic studies (3)
Recommendation
Dental Implants can be placed successfully and
restored in patients with RDEB.
2. What are the benefits and advantages in quality
of life for patients with RDEB after rehabilitation
with dental implants?
Summary of evidence
Oral rehabilitation with dental implants improved the
patient’s quality of life by:
1. Oral function: 5,8,20–28
a. Improved chewing (helping to improve nutrition)
b. Improved oral stage of swallowing
c. Improved speech
2. Aesthetics, increasing self-esteem and sociability
(Image 4.1).5,8,20,21,23–28
3. Comfort, because of the improved retention of the
prostheses.21
4. Oral health status, as it reduced the risk of soft tissues
trauma.20,28
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TABLE 4 . 1 Summary of success rate of dental implants in patients with RDEB
Appraised literature N◦ of
Patients
N◦ of
implants
1-year
osseointegration
success rate
3-year
osseointegration
success rate
5-year
osseointegration
success rate
Rehabilitation
success rate
Peñarrocha -Diago, 20005 4 15 100% 100% (7) NA 100%
Peñarrocha, Rambla; 200720 3 27 96.3% (27) 100% (18) 100% (20) 100%
Peñarrocha, 200721 6 38 97.4% 100% (29) 100% (20) 100%
Lee, 200722 1 8 100% NA NA 75%,
fixed successfully
Larrazabal, 20098 1 2 100% NA NA 100%
Oliveira, 201023 1 2 100% NA NA 100%
Müller, 201024 1 10 100% 100% NA 50%,
fixed successfully
Peñarrocha, 201125 6 36 100% (36) 100% (16) NA 100%
Peñarrocha, 201226 4 23 100% (23) 100% (4) NA 100%
Agustín-Panadero, 201527 1 8 87.5% NA NA 100%
Guzmán, 201628 1 11 100% (6) 100% (6) NA 100%
Agustín-Panadero, 201729 1 4 100% NA NA 100%
Molina, 201730 1 7 100% 100% NA 100%
Agustín-Panadero, 201931 4 31 100% 100% NA 100%
aKey: NA, information not available; N, total number reported in the article. Number in brackets: number of implants reported with the specific follow-up time.
IMAGE 4 . 1 Thirty-seven-year-old woman with severe reces-
sive DEBwho acknowledges improved aesthetics after complete den-
tal implant supported rehabilitation
Level of evidence
∙ Nonanalytic studies (3)
Recommendation
Performing dental implants in patients with
RDEB is recommended, as patients improve their
quality of life through enhanced oral function-
ing, aesthetics, comfort, and general oral health
status.5,8,20-29
3. Which are the benefits of a fixed implant-
supported denture compared to a removable
implant-retained denture in patients with RDEB?
Summary of evidence
Fixed implant-supported dentures produce less risk of
soft tissue trauma. There is less mechanical irritation to
the oral mucosa and patients do not need to remove
them.20–22,24,28
Fixed implant-supported dentures result in a higher sat-
isfaction level as reported by the patients, when compared
to removable implant-supported dentures.21,25
Level of evidence
∙ Nonanalytic studies (3)
Recommendation
Fixed implant supported dentures should be pre-
ferred as they provide more advantages than
removable implant supported dentures.21,25
4. Which are the main challenges of placing
implants in patients with RDEB? (If reported,
specify the patient’s maximal mouth opening.)
Summary of evidence
The main challenges when performing implant surgery
in patients with RDEB are:
1. Accessing the surgical site is complicated because of
severe microstomia, severe ankyloglossia, and obliter-
ation of oral vestibule (Image 4.2).5,20,21,23–29
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IMAGE 4 . 2 Severe microstomia limiting access to surgical
field, mucosal sloughing can be observed on the tongue surface
IMAGE 4 . 3 Limited alveolar height on a maxillary bone of a
patient with RDEB
2. Surgery is challenged by skin and mucosa fragility,
tissue sloughing, and formation of blood-filled bul-
lae and blistering complications at minor trauma
(Image 4.2).5,8,20,21,23–28
3. Choosing a site to place the implant is challenged by
severe alveolar bone atrophy (Image 4.3).20,25,29
4. Oral rehabilitation (dental prosthesis) is chal-
lenged by microstomia and difficulty in taking
impression.20,23,25,27,29
Level of evidence
∙ Nonanalytic studies (3)
5. Does osteoporosis affect dental implant osseointe-
gration in patients with RDEB?
Summary of evidence
Even though osteoporosis is a clinical feature of RDEB32
and clinically patients present with severe alveolar bone
atrophy,5,20,21,25,26,33 implants osseointegrate successfully.
The success rate after 1 year, as observed in question 1, is
98.6%.
Level of evidence
∙ Nonanalytic studies (3)
A
B
C
IMAGE 4 . 4 Panoramic radiograph (A) and cone-beam tomog-
raphy (B and C) are themain preoperative images needed for surgery
planning
Recommendation
Implant success rate does not seem to be affected by
osteoporosis (osseointegration 98.6% after 1 year).
Nevertheless, the panel of experts suggests con-
ventional or delayed loading of the implants to
minimize the risk of failure. More information is
provided in question 21.
6. Which preoperative tests are needed when plan-
ning dental implants in patients with RDEB?
Summary of evidence
Reported clinical cases and case series have used
panoramic radiograph,5,8,20,21,23,25–27,29-31 cone-beam com-
puterized tomography,5,8,20,21,23,25–31,33 and stereolitho-
graphic models23 to plan the surgery and rehabilitation.
Level of evidence
∙ Nonanalytic studies (3)
Recommendation
Imaging:
When planning implant surgery, a panoramic
radiograph and cone-beam-computerized tomog-
raphy should be assessed (Image 4.4)
Models:
If available, stereolithographic models can be use-
ful to help plan the implant surgery in a noninva-
sive manner.
7. What is the best time frame between dental
extractions and implant placement in patients
with RDEB?
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IMAGE 4 . 5 Nonadherent dressings protecting the skin and
eyes. Lips are well lubricated
Summary of evidence
There have been reports of immediate implant place-
ment after extraction,23,27,29 as well as implant surgery
3 months28 and 6 months after extraction.22 The litera-
ture reviewed does not provide enough information on the
diagnosis of each tooth, in order to provide a clear guide-
line or recommendation.
Level of evidence
∙ Nonanalytic studies (3)
Recommendation
Whenever possible, immediate implant placement
after the dental extraction should be considered to
reduce the number of interventions.
8. What are the special precautions that need to be
takenwhenhandling fragile skinandmucosadur-
ing oral surgery in patients with RDEB?
Summary of evidence and recommendations
(i) Patient’s skin should be carefully cleaned with anti-
septics prior to surgery and cover with lubricants or
emollients to reduce the possibility of mechanical
trauma to the skin. Special nonadherent dressings
can be used (Image 4.5).20,21,23 More information can
be found in Chapter 3: Oral health care and dental
treatment for children and adults living with EB—
CPGs.
(ii) Extreme care when handling skin and mucosa will
avoid or reduce the formation of new lesions. To han-
dle tissues, a little pressure (compressive forces) can
be applied, but no sliding movements (lateral trac-
tion or other shear forces) should be used, as these
can cause tissue sloughing. Be gentlewhen stretching
mucosa with intraoral mirror. Avoid friction between
intraoral mirror or separators and mucosa.5,25,29,33
IMAGE 4 . 6 Lips lubricated with petrolatum
IMAGE 4 . 7 Local infiltration should not be superficial, as it
could separate the mucosal layers
(iii) Lips should always be lubricated before any pro-
cedure is performed; to reduce adherence, shear-
ing forces leading to tissues separation, and lesions
formation (Image 4.6).5,8,20,21,25-29,31,33 Examples of
commercially available lubricants or emollients are
petrolatum Vaseline R© (Unilever) and Linovera R©
(B.Braun).
(iv) When using local anesthesia, the liquid should be
injected deeply and slowly into the tissues to prevent
tissue distortion thatmay cause tissue separation and
blistering (Image 4.7).5,21,23,26,28
(v) To reduce the need of aspiration, a minimal amount
of irrigation with saline should be used. Avoid con-
tact of aspiratorwithmucosa. The aspirator should be
in contact with bone and not the soft tissues to avoid
tissue sloughing (Image 4.8).5,8,25,26,28,33
IMAGE 4 . 8 Aspirator or suction tip should be leaned on hard
tissue (bone)
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IMAGE 4 . 9 Blood-filled bulla drained with a sterile scissor
(vi) Use small suction tips and flat tissue retractors.23
(vii) Blood or fluid-filled bullae that occur during treat-
ment should be drained with a sterile needle or by
a cut with scissors to avoid lesion expansion due to
fluid pressure (Image 4.9).29
9. Would implants reduce the functional space
between upper and lower arch thus limiting the
space to eat?
Summary of evidence
The changes in functional space between upper and
lower arch before and after implant rehabilitation, which
is a concern for patients considering this treatment, have
not been specifically quantified in the literature. However,
data published onmouth opening and quality of life can be
an aid for patients undergoing an evidence-based decision
process.
Quantitative measurement and changes:
The patient receiving full arch fixed prothesis byMolina
in 2017 had an initial maximal mouth opening of 22 mm
and her quality of life improved after rehabilitation.30 Lee,
in 2007, highlighted the importance of a framework wax-
up to assess the functional space, and analyses that fixed
complete dentures require less space than overdentures,
therefore allowing more functional space.22
Qualitative changes:
Patients unable to bite before treatment reported to be
able to chew better after the rehabilitation.20 The patients’
masticatory functionwas self-reported as having improved
considerably as a result of treatment.8,27
The general satisfaction questionnaire after oral implant
rehabilitation (considering general satisfaction, eating,
speech, aesthetics, hygiene, comfort, and self-esteem on a
scale from 0 to 10, being 0 = “not at all satisfied” and 10
= “totally satisfied”) scored on average: 9.6,21 9.0,25 9.2,26
and 9.5.28 Specifically for the question on satisfaction with
“Eating ability” after fixed rehabilitation in the same scale,
25% of the patients scored 9 and 75% of the patients scored
10.31
Level of evidence
∙ Nonanalytic studies (3)
Recommendation
In patients with partial edentulism, fixed implant-
supported oral rehabilitation improves the eating
ability.
In patients with total edentulism, a fixed full-arch
oral rehabilitation allows the mastication.
4.2 Prescriptions (questions 10 and 11)
10. What antibiotic prescription should be consid-
ered when planning a dental implant surgery in
patients with RDEB?
Summary of evidence
Most authors prescribe amoxicillin 500mg every 8 hours
for 7 days.5,8,20,21,23,25–27,29,31 One author also includes a pre-
operative dose23 and another author added clavulanic acid
to the amoxicillin.28 There is no report of any infectious
related complication. None of the patients had known
antibiotic allergy. History of allergies always needs to be
assessed on an individual basis and considered prior to pre-
scription.
Level of evidence
∙ Nonanalytic studies (3)
Recommendation
Antibiotic treatment should follow standard
implant surgery protocols.
11. What analgesia, anxiety, and pain management
strategies should be considered when planning a
dental implant surgery in patients with RDEB?
(Consider preoperative, perioperative, and post-
operative measures.)
Summary of evidence
Analgesia and pain management
Only one author used preoperative pain management,
more precisely piroxicam 20 mg 1 hour before surgery.23
During surgery,most authors used articaine 4% as the local
anesthesia of choice.8,25–29 Other authors have used mepi-
vacaine 2%.23
To manage postoperative pain, most authors prescribed
ibuprofen 600 mg every 8 hours for 3 to 7 days,8,20,21,25–29,31
while others prescribed ibuprofen 400mg every 8 hours for
3 days5 or piroxicam 20 mg once a day for 5 days.23
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Anxiety management
While some authors use only behavioral management
techniques,23,29 most authors use sedation8,20,21,25–28,31 and
others general anaesthesia.22,24
Level of evidence
∙ Nonanalytic studies (3)
Recommendation
For the pain management:
1. Use of local anesthesia, injected deeply into the
tissue at a sufficiently slow rate to prevent tis-
sue distortion.
2. The use of NSAID postoperative, following
standard protocols.
For anxiety management during surgery, we sug-
gest revising the section on behavioral support
(Chapter 3) and Chapter 5 on sedation and anes-
thesia.
4.3 Implant surgery (questions 12 to 20)
12. Which special considerations need to be taken
during the incision when performing a dental
implant surgery in patients with RDEB?
Summary of evidence
Most authors perform extensive supracrestal incisions
with small lateral discharges to allow the separation of
sufficiently large full-thickness flaps with the aim of
preventing tension to the flap during retraction, as the
force applied by separators could cause mucosal damage
(Image 4.10).5,8,20,27,28,33 The tissuesmust be tractioned in a
gently way.8,23,33 The detachment must be mucoperiosteal,
complete, and careful (Image 4.11).8,27,33
IMAGE 4 . 1 0 Supracrestal incision
IMAGE 4 . 1 1 Mucoperiostal detachment
Only one author has described a different technique.
Molina, in 2017, performed a flapless surgical approach for
the installation of mini-implants.30
Level of evidence
∙ Nonanalytic studies (3)
Recommendation
∙ The supracrestal incision should be extensive
and include release incisions to expose the
bone.
∙ The detachment must be mucoperiosteal (full
thickness), complete, and careful.
∙ The tissues must be tractioned in a gently way.
13. Which types of implants have been used success-
fully in patients with RDEB?
Summary of evidence
As observed on the table of evidence (Table 4.2), all
the publications of implants in EB report the use of
endosseous implants. Most authors have used tissue level
implants, whileOliveira in 2010 chose bone-level implants.
Self-tapping implants have been placed, either tapered or
straight. Bioactive and modified surface implants have
been used. One author used mini implants.
Level of evidence
∙ Nonanalytic studies (3)
Recommendation
∙ Endosseous self-tapping implants have been
used successfully in patients with RDEB.
∙ The shape can be either tapered or straight
and the surface can be bioactive or modified,
depending on the patient’s bone quality.
14. Which surgical technique should be used for
placing dental implants in the upper maxilla of
patients with RDEB?
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TABLE 4 . 2 Types of dental implants used in previous publications
Reference Type of Implant Brand name
Peñarrocha-Diago, 20005 Endosseous—Tissue level Titanium Plasma Sprayed (TPS) ITI (Straumann)
Peñarrocha, Ramblas, 200720
Peñarrocha, 200721
Lee, 200722 Endosseous—Tissue level
titanium sandblasted/acid-etched (SLA) surface
Straumann standard plus
Larrazabal, 20098 Endosseous—Tissue level
Titanium Avanblast Surface—Self-tapping
Defcone TSA
Oliveira, 201023 Endosseous—Bone level
TPS + Hydroxyapatite (HA)
IMZ twin implants
Peñarrocha, 201125 Endosseous—Tissue level
Chemically modified / SLA surface
Phibo TSA Avanblast surface/ITI
SLA surfacePeñarrocha, 201226
Agustín-Panadero, 201527 Endosseou—Tissue level
chemically modified
Phibo TSA Avanblast surface
Guzman, 201628 Endosseous—Tissue level—self-tapping
Titanium—TMX surface (physical surface features)
HA MP1 covering (chemically modified surface)
Zimmer TSV
Agustín-Panadero, 201729 Endosseous—Tissue level
Titanium grade II—chemically modified
Phibo TSA Avanblast surface
Molina, 201730 Endosseous—Tissue level
Self-tapping- chemically modified—Mini-implants
Not reported
Agustín-Panadero, 201931 Endosseous—Tissue level
Titanium grade II—chemically modified
Phibo TSA Avanblast surface
Summary of evidence
It is widely described that patients with RDEB present
marked alveolar atrophy. Therefore, most authors agree
that conventional mechanized instruments could weaken
the residual bony process, thus precluding primary reten-
tion of the implants. In 2000, Peñarrocha5,33 described the
successful use of the osteotome technique in themaxilla of
patients with RDEB. Thereafter this technique has widely
been used by most authors. Depending on the clinical fea-
tures of the patients, drills are combined with osteotomes
to preserve the bone and facilitate achievement of pri-
mary stability (Images 4.12 to 4.14).20,21,25,26,28,31 Irrigation
with saline is used as minimal as possible to avoid dam-
age caused by the action of the suction tip.24,27,29,31 The
only author describing a different technique was Müller
who published a clinical case using the underdrilling
technique.24
Level of evidence
∙ Nonanalytic studies (3)
Protocol recommended by the panel of experts for plac-
ing dental implants in the upper maxilla of patients with
RDEB
∘ For patients with severe atrophy of the maxillary bone,
a combined drill and osteotome technique is recom-
mended: 5,20,21,25,26,33
IMAGE 4 . 1 2 Low-velocity drilling
▪ An initial low-velocity drill withminimal irri-
gation is used to create a small opening in
the residual bone to allow for the insertion of
osteotomes of small diameter.28
▪ Expansion osteotomes are used to facilitate
obtaining primary stability while avoiding
bone removal.
▪ The implants are inserted using a low-velocity
drill technique with no irrigation.27,29
64
IMAGE 4 . 1 3 Expansion osteotomes
IMAGE 4 . 14 Implant insertion
15. Which surgical technique should be used for
placing dental implants in the mandible of
patients with RDEB?
Summary of evidence
In the mandible, the conventional rotatory technique
is used to place dental implants in patients with RDEB
(Image 4.15).5,8,20,21,25,26,31,33 The amount of irrigation with
saline varies between authors.
IMAGE 4 . 1 5 Rotatory technique with little saline irrigation.
Suction tip leaned on the bone
Specific precautions should be taken, such as:
∘ Securing a sufficiently large surgical field to allow
working on the bone without inducing soft tissue
tension.20,21
∘ Minimum sterile saline solution should be used.20,31
There is a report where abundant irrigation with saline
was used, but the surgical management was compli-
cated due to the formation of bleeding bullae afterminor
trauma.8 Therefore, the panel of clinical experts recom-
mends the use of moderate amount of irrigation.
∘ Aspiration should be donewith the suction tip in contact
with the bone, not the soft tissues.20,21,31
Müller and coworkers used the same technique as for
the maxilla: the underdrilling technique, with the aim of
improving primary stability.24 This should be considered
to enhance primary stability if the surgeon detects that the
bone has low density while drilling.
Two authors have planned to use guided surgeries.22,23
In the first report, the surgical guide was used successfully
to place two single implants in the area of the lower cen-
tral incisors.23 In the second report, however, the surgery
was performed on a completely edentulous patient and the
surgeons were unable to stabilize the mandibular surgical
guides due to intraoral soft tissue scars, having to place the
implants without a guide.22
It is considered a good practice to obtain a postoperative
panoramic radiograph25,26,31
Level of evidence
∙ Nonanalytic studies (3)
Protocol recommended by the panel of experts for placing
dental implants in the mandible of patients with RDEB
∘ Conventional rotatory technique with:
▪ Large surgical field to allow working on the
bone without inducing blisters.
▪ Reduced amount of sterile saline solution.
▪ Suction tip in contact with the bone, not the
soft tissues.
▪ Consider undersized drilling if atrophic bone
hinders primary stability.
16. Which type of bone grafting should be used dur-
ing implant surgery in patients with RDEB?
Summary of evidence
According to the available body of evidence, it is
possible to use bone grafting to regenerate peri-implant
defects.8,25,26,29 Autologous bone collected from the for-
mation of the implant bed or from a donor site,8,25,26,31
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IMAGE 4 . 1 6 Tricalcium phosphate synthetic particulate
block graft from retromolar area fixed with osteosynthe-
sis screws,8 tricalcium phosphate synthetic particulate
bone (Image 4.16),25,26,29,31 and collagen absorbable
membranes25,26,31 have been used successfully. A nonab-
sorbable titanium-reinforced membrane has also been
reported in one case.26
Level of evidence
∙ Nonanalytic studies (3)
Recommendation
∘ Use the standard surgical bone graft protocols
depending on each case.
∘ Absorbable membranes are preferable to avoid
a second surgery.
17. Which type of interimdenturehas beenused suc-
cessfully in patients with RDEB?
Summary of evidence
Oliveira reported the use of an immediate prosthetic
rehabilitation. This case reports two single tooth replace-
ments using dental implants.23 Only 2 out of 13 authors
describing full arch rehabilitation reported the use of
an interim (temporary) removable prosthesis during the
osseointegration period. The first was tissue-supported
and was lined with tissue conditioner every 2 weeks,31 the
second was implant-supported.30 Other authors consid-
ered interim dentures difficult to use.
Level of evidence
∙ Nonanalytic studies (3)
IMAGE 4 . 17 Implants left submerged after surgery.
Resorbable sutures
IMAGE 4 . 1 8 Exposed healing caps after surgery and prior to
rehabilitation
Recommendation
There is insufficient evidence to provide a recommenda-
tion on this question. Single-tooth replacement might be
able to use an interim restoration. For full arch rehabilita-
tion, it will depend on the patient’s mucosal tolerance to
wear interim dentures.
18. Should implants be left to heal submerged or
exposed?
Summary of evidence
Both techniques have been used in patients with
RDEB.28 Implants in which bone regeneration was per-
formed were left submerged (Image 4.17).25,31 When
implants were left submerged, second-stage surgery was
performed between 3 and 6 months later.8,27,31
It has been observed that during the osseointegration
period, the rounded healing caps can cause ulcers on the
tongue (Image 4.18 and 4.19).24 This, however, does not
contraindicate its use.
Level of evidence
∙ Nonanalytic studies (3)
Recommendation
There is no difference in decision process when
compared to healthy patients. The first choice is
to leave the implants exposed to heal, to avoid sec-
ond surgery. Implants are left to heal submerged in
patients with RDEB whenever primary stability is
not achieved, when bone regeneration procedures
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IMAGE 4 . 1 9 Implant caps indents on the tongue during
osseointegration period
are done simultaneously to implant placement, or
if there are oral hygiene difficulties.
19. Which type of suture can be safely used in
patients with RDEB?
Summary of evidence
Suturing techniques successfully used include horizon-
tal mattress8 and sutures applied with no5 or little33 ten-
sion. The types of sutures successfully used include silk
sutures (4-0)23 and absorbable polyglactin sutures (3-0)
(Vicryl, Johnson & Johnson, New Brunswick, NJ, USA)
(Image 4.17).28 In all the cases, the sutures were removed
after 1 week.23,25–27,29
Level of evidence
∙ Nonanalytic studies (3)
Recommendation
∘ Sutures have to be applied without tension.
∘ Avoid rigid sutures that will damage the soft tis-
sues during the postoperative phase.
20. What special postoperative instructions need to
be considered after implant surgery in patients
with RDEB?
Summary of evidence
It is important to highlight that even though patients
with RDEB have marked skin fragility; ulcers and tis-
sue sloughing occurs during surgery; postoperative course
is normal in most patients.25 The postoperative instruc-
tions given to the patients include the use of ultrasoft
toothbrushes and to perform daily mouthwashes with an
alcohol-free chlorhexidine.23,30 Patients were instructed to
eat cold liquid food for 48 hours postsurgery.23 Mouth
rinses aimed at tissue healing such as Gelclair R© (Helsinn
Healthcare SA, Switzerland), Dentoxol R© (Ingalfarma,
Chile), and K-trix R© (Farpag, Colombia) can be considered
IMAGE 4 . 2 0 Oral hygiene cleaning the intaglio surface with
interproximal brush
during the postoperative course. A patient representative
reported successful use of saltwater mouthwash as a low
cost, easily accessible alternative. No studies have been
identified on their impact for intraoral tissue healing after
surgery in patients with EB.
Long-term instructions include brushing the prosthe-
sis with a soft brush while avoiding the soft tissues. The
hygiene of the intaglio surface of the prosthesis could be
carefully addressed via a dental water flosser using a low-
pressure setting29 or an interproximal brush (Image 4.20).
Level of evidence
∙ Nonanalytic studies (3)
Recommendation
∘ Ultrasoft toothbrush to clean thewound and the
healing abutments.
∘ Mouthwash: rinsing themouthwith an alcohol-
free chlorhexidine 0.12%mouthwash twice a day
for 7 to 10 days, or a mouthwash aimed at tissue
healing, can be considered.
∘ The patientwas instructed to eat cold, liquidized
food for 48 hours postsurgery.
4.4 Implant rehabilitation (questions 21
and 22)
21. What is the best time for loading dental implants
in patients with RDEB?
Summary of evidence
Implants have been left to osseointegrate for 3
months in the mandible5,20,21,25–27,30 and 6 months in
the maxilla.5,8,20–23,25-27
Level of evidence
∙ Nonanalytic studies (3)
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IMAGE 4 . 2 1 Customized acrylic tray used for an open tray
technique. Copings were secured with acrylic resin. Patients’ limited
mouth opening is a challenge for screw manipulation
Recommendation
∘ Conventional or delayed loading protocols
should be followed to minimize the risk of fail-
ure. Implants should be loaded after 3 months
in mandible and after 6 months in maxilla.
22. Which types of prostheses have been used suc-
cessfully in patients with RDEB?
Summary of evidence
Impression taking
The first step to design prostheses is to take an ade-
quate impression. Due to the patient’s limitedmouth open-
ing, this procedure can be challenging.22 Most clinicians
do manage to take the impressions without the need of
pharmacological patient management; however, a case of
impressions and bite registration during general anesthe-
sia has been reported.24
As regard to the trays, only two authors have reported
the use of conventional trays to take the impressions.24,27
The other authors have designed small, customized,
acrylic individual trays28,33 or placed heavy silicone
directly in the mouth.29 Both the closed27,28 as well as the
open tray techniques have been used. The copings have
been secured to the implants and connected with den-
tal floss and joined with acrylic resin (Image 4.21).22,23
Another alternative is to connect the copings with plastic
sprue bars and acrylic resin.22 For the maxillary impres-
sion, one author modified the surgical guide to use it as
a custom tray.53 Medium or light-bodied viscosity impres-
sion material is applied around the assembly to record the
position of the implants.22,23 To pour the impression, the
analogs are connected to the impression copings and arti-
ficial stone together with gingival mask is used to fabricate
the definitive cast.23,27 Facebow records and amaxillofacial
relation record can be obtained.22
Recently, Agustín-Panadero and coworkers reported the
use of digital intraoral scanners to register the implant
position, avoiding the need of conventional impression
technique.31
Oral rehabilitation
The first reports of oral rehabilitation with dental
implants were published by Peñarrocha in 2000, using
overdentures.5 Thereafter the same group, as well as all the
other authors, have chosen fixed (either cemented27,28 or
screwed24,29) rehabilitation.8,23,26 Most rehabilitations con-
sist of fixed short arch implant-supported prosthesis for
complete edentulous patients.20,22,25–31 The short arch (one
premolar and one molar) is chosen because of the sever-
ity of microstomia.20,24–27,30,33 The materials used include
metalceramic (Images 4.22 to 4.24),23,27,28 gold alloy frame-
work with acrylic resin denture teeth,24 and metal-resin
(when financial limitations do not allow the use of metal-
ceramic).22 Some specific denture design modifications
to overcome difficulties related to microstomia include:
the superstructure had to be horizontally screwed onto a
milled bar mesostructure, because the limited space pre-
cluded access with a screwdriver for direct vertical screw
retention.24 Some authors have had screw-access holes
perforating the buccal surface of the denture and have
closed them using composite resin.22,31 This specific modi-
fication has been necessary either because the mandibu-
lar implants were placed labially22 or to overcome the
difficulty of accessing the screws due to microstomia.31 As
to the prostheses design, bibalanced occlusion is chosen.33
The design needs to allow space between the intaglio sur-
face of the denture and the oralmucosa so that the prosthe-
sis can be easily cleaned. Only the maxillary anterior area
has slight contact on themucosa tominimize possible pho-
netic problems.22
Summary
Types of prostheses that have been reported as successful
in patientswithRDEB: (a) Fixed full-short arch prostheses,
(b) fixed overdenture, and (3) fixed partial denture.
Level of evidence
∙ Nonanalytic studies (3)
Recommendation
Specific patient’s oral structures need to be considered to
choose the type of prosthesis that fits their specific require-
ments. The first option should be:
∙ For edentulous patients: Fixed full-short arch
prostheses.
∙ For single implants: Fixed partial denture.
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IMAGE 4 . 2 2 Implant abutments IMAGE 4 . 2 3 Metal framework IMAGE 4 . 2 4 Fixed short arch metal-
ceramic complete oral rehabilitation
4.5 Follow-up (questions 23 and 24)
23. Which complications have been reported dur-
ing or after implant supported rehabilitation in
patients with RDEB?
Summary of evidence
During implant surgery
In all cases, blister complications were recorded dur-
ing the operation (Image 4.25). However, the postoperative
course was normal.8,20
Difficulties during impression taking
The patient’s limited mouth opening challenges the
impression procedure (Image 4.21).22
Some authors have not been able to perform a full dig-
ital protocol including an intraoral scan as part of the
prosthodontic management because the scan sensor could
not be fitted in the mouth of the patient and saliva could
not be aspirated atraumatically.29
After implant supported rehabilitation
Most authors describe a normal postoperative course
with no complications.5,23,25,26 Isolated cases have reported
poor oral hygiene22 and mucositis at the implant sites, but
without additional changes in peri-implant bone levels.27
During the osseointegration period, the rounded healing
caps can cause ulcers on the tongue.24 A detailed descrip-
IMAGE 4 . 2 5 Tongue mucosa sloughing during implant
surgery
tion on hygiene and gingival scores follow-up can be found
in the study published by Agustín-Panadero in 2019.31
Rehabilitation failures have also been described: The
metal framework of a patients’ rehabilitation fractured
at the solder joint. The fractured section was repaired
successfully.22 In another patient, the lingual position of
themandibular implants resulted in prognathism, proving
amechanical disadvantage that led to fractures of the abut-
ments. Encouraged by the clinical stability of the implants,
more implants were placed in themandible, improving the
occlusal stability and allowing successful rehabilitation.24
Level of evidence
∙ Nonanalytic studies (3)
24. What is the best frequency ofmaintenance recall
appointments after implant supported rehabili-
tation in patients with RDEB?
Summary of evidence
Most authors recommend monitoring the patient 1 and
3 months after implant placement and implant rehabil-
itation. Thereafter, the patient should be engaged in a
monitoring schedule. The appointments should be every
2 or 3 months the first year,20,21,25–29,31 and thereafter on a
biannual schedule.30 Panoramic radiographs should be
taken after 6 months, 12 months, and every 12 months
thereafter (Image 4.26).20,21,25,26,31 Most authors do not
remove the rehabilitation to perform the cleaning ses-
sion. Only one author removed the abutments for hygiene
purposes.24
Level of evidence
∙ Nonanalytic studies (3)
Recommendation
∙ The patients should be clinically evaluated at 1
week, 1 month, and 3 months after the implant
surgery.
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IMAGE 4 . 2 6 One-year follow-up panoramic radiograph
∙ After the implant rehabilitation, the patient
should be monitored after 1 week and 1 month.
∙ Dental hygiene sessions should be scheduled
every 3 to 6 months thereafter.
∙ Radiographs should be obtained every 12
months.
∙ Prosthesis should only be removed if there is a
problem, not for standard cleaning.
Images
Wewould like to acknowledge the support of patients, clin-
icians, and researches from different clinical centers glob-
ally for collaborating by providing images for the present
guideline. Written informed consent has been obtained for
all images where patients can be recognized. Images pro-
vided by Dr. Marcelo Guzman-Letelier, Dr. Antonio Oli-
vares, and Dr. Susanne Krämer.
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CHAPTER 5: Sedation and anesthesia for adults and
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Introduction
Children and adults living with Epidermolysis Bullosa
(EB) present fragile skin and mucosa, requiring a special
approach from the health care team. When planning a
dental procedure under sedation or general anesthesia,
the entire clinical team must be aware of the appropriate
precautions that individuals with EB may require to
receive optimal care. The first clinical practice guideline
(CPG) on oral health care for patients with EB was pub-
lished in 2012.1 As new evidence has been published since
it has become necessary to update the guideline ensuring
that all new data are incorporated, as well as including
more experts from different centers around the world to
discuss the different treatment options and to work toward
establishing the best CPGs. The present guideline has
been entrusted by DEBRA International, the worldwide
network working on behalf of those living with EB. It
follows a standard methodology based on a systematic
review of the currently available scientific evidence and a
panel discussion.
Aim
To provide the users with information on the current best
practice for managing local anesthesia, principles of seda-
tion and general anesthesia for children and adults with
EB undergoing dental treatment.
Health question covered in the guideline
Do patients with EB undergoing dental treatment under
sedation or general anesthesia need specific precautions or
treatment modifications compared to healthy individuals
to avoid trauma to the skin and mucosa?
Users
Specialists in Pediatric Dentistry, Special Care Dentistry,
Oral and Maxillofacial Surgery, Endodontics, Periodon-
tics, Rehabilitation and General Dental Practitioners,
Nurses, Anesthetists, Pediatricians, Dermatologists, and
other health care professionals managing patients with EB
whoneed dental treatment under sedation or general anes-
thesia.
Target group
These guidelines can be applied to all patients diagnosed
with EB regardless of the type of EB. They are therefore
applicable to all four major types of EB: EB simplex, junc-
tional EB, dystrophic EB, and Kindler EB.
Methodology
Systematic literature searching
Literature sources
A systematic literature review was performed to iden-
tify all the literature on sedation and anesthesia for
patients with EB undergoing dental treatment. The lit-
erature search ranged from 2010 to March 2018. Con-
sulted sources included the electronic databases MED-
LINE (2010 toMarch 2018), EMBASE (2010 toMarch 2018),
CINAHL (2010 to March 2018), The Cochrane Library
(2010), DARE (2010), and the Cochrane controlled tri-
als register (CENTRAL) (2010). In addition, hand search-
ing journals, reviewing conference proceedings, and other
guidelines sources such as DEBRA International Guide-
line depository were carried out. The reference lists of
all papers for relevant citations were reviewed. When all
the relevant studies were identified, they were sent to the
experts to review for completeness.
Selection criteria of the articles
Selection criteria of the articles: primary or secondary arti-
cles in which the main topic is dental care and anesthesia
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F IGURE 5 . 1 Method used for formulating the recommendations as described on the 50 Guideline Developer’s Handbook, NHS Scottish
Intercollegiate Guidelines Network SIGN. Revised Edition January 20082
(diagnosis, and/or treatment and/or prognosis) in patients
withEB, published between 2010 and 2018 in any language.
Search strategy
To identify studies for this review, detailed search strate-
gies were based on the search strategy developed forMED-
LINE; but revised appropriately for each database. The
search strategy used a combination of controlled vocabu-
lary and free text terms based on:
#1 "Epidermolysis Bullosa"[Mesh],
#2 ((Epidermolysis[tiab] OR Acantholysis[tiab]))
AND Bullosa[tiab]
#3 "Dentistry"[Mesh]
#4 "Oral Health"[Mesh]
#5 "Mouth Diseases"[Mesh]
#6 "Dentistry"[tiab]
#7: #1 OR #2;
#8: #3 OR #4 OR #5 OR #6;
#9: #7 AND #8;
#10: #9 AND ("2010/11/01"[PDat] : "2018/03/01"
[PDat]).
Methods used for formulating the
recommendations
To formulate the recommendations of the selected studies,
the SIGN system was used as described on the 50 Guide-
line Developer’s Handbook, NHS Scottish Intercollegiate
Guidelines Network SIGN. Revised Edition January 20082
(Figure 5.1).
Guideline development process
The information from the selected studies was gathered in
a draft document by the clinical leads and methodologists.
The draft document was analyzed and discussed at a con-
sensus meeting held in Santiago, Chile, on October 23rd,
2018, by the clinical experts guided by the methodologists
as described in Tables 2 and 4 (see page 3 and 4).
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The consensus reportwas reviewed by nine external spe-
cialists, two members of the multidisciplinary EB team,
and three patient groups as described in Tables 3 and 5 on
page 3 and 5. Patients and representatives from theDEBRA
association groups reviewed the document to ensure that
the degree to which the evidence addresses patients’ con-
cerns is reflected in the guideline.
The final version was piloted in three centers from
three different countries for 3 months (September 2019 to
December 2019) as described in Table 6 (page 4).
Guideline implementation and monitoring
Implementation barriers
According to the context of implementation of this guide-
line, some barriers to be considered are:
▪ Access to training in EB-specific issues.
▪ Insufficient availability of health services in some parts
of the world.
Guideline monitoring and/or auditing
criteria
The implementation of these recommendations could be
monitored and evaluated through audits and completing of
the “CPGEvaluation Form: Pre implementation” available
on DEBRA International web page (https://surveyhero.
com/c/aabc0100). The panel recommends clinical sites to
conduct prepractice audit, implement the CPG, and reau-
dit to test improvements. Audit tools can be used from
SIGN35. DEBRA International would value your feedback
on the site findings to continue to improve CPG quality.
Further areas of research
∙ Continuous follow-up of the recommendations stated in
this guideline.
Guideline updating procedure
The guideline will be updated every 5 years after its sec-
ond version. If new relevant evidence is detected before the
update, the information will be published on the web site
http://www.debra-international.org/.
The team in charge of this update will be formed by Prof.
Susanne Krämer and Prof. James Lucas in 2025.
RESULTS
Anesthetic management of children and
adults with epidermolysis bullosa
undergoing dental treatment
Children and adults livingwith EB can receive dental treat-
ment using local anesthesia, sedation, or general anes-
thesia. The decision of which anesthetic modality to be
used is decided after a detailed risk assessment is under-
taken as well as a detailed discussion with the patient
and/or family members for children. The discussion usu-
ally includes risks, benefits, advantages, and disadvantages
of each technique, as well as the alternatives based on
what is available in the local specialized services. There are
many factors that can influence the final decision such as
the patient’s age,3 extent of dental treatment required,3,4
and the patient’s acute stress reaction.3 It is important to
highlight that sedation should only be performed if all the
expertise and resources for emergency access of critical air-
way are available.
For patients with mild forms of EB; simple, atraumatic
dental procedures can be performed safely under local
anesthesia as the technique of choice. General anesthesia
is therefore reserved for extensive, more complex proce-
dures or for patients with severe forms of EB. The support
of an experienced medical team is crucial in this setting.
5.1 Local anesthesia
Provided a risk assessment is undertaken and microsto-
mia can be managed, all dental treatment techniques can
be provided successfully under local anesthesia, including
multiple extractions, implants, RCT, and restorations.5–7
The benefits of local anesthesia when compared to gen-
eral anesthesia are avoidance of potential damage to the
airway and the provision of prolonged postoperative pain
relief. Additional benefits have also been reported8 includ-
ing lower cost of care and absence of hospitalization,
thus reducing the risks of general anesthesia and hospi-
tal acquired infections. Less mucosal damage is usually
reportedwhen procedures are performed under local anes-
thesia when compared to procedures performed under
general anesthesia.
Topical anesthesia in gel form can be used nor-
mally.
To avoid bullae formation, the anesthetic solu-
tion must be injected deeply into the tissues and
at a slow rate in order to avoid having the liq-
uid cause mechanical separation of the tissue7,9,10
(Image 5.1).
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IMAGE 5 . 1 Blood filled bulla at an injection site
IMAGE 5 . 2 Drainage of a blood-filled bulla with a sterile nee-
dle
Computer-controlled local anesthetic delivery sys-
tems, such as The Wand STA R© (Milestone Scien-
tific Inc., Livingston, NJ, USA) and Dentapen R©
(Juvaplus SA, Geneva, Switzerland), can be ben-
eficial in providing anesthesia.
Iatrogenic bullaemay develop following local anes-
thetic injection.5,7,11,15 These have to be drained
immediately with a sterile needle or by a cut with
scissors to avoid lesion expansion due to fluid pres-
sure. The overlying mucous membrane (roof of
the blister) should not be removed as it acts like a
natural dressing and aids healing, reducing pain,
and minimizing the risk of exogenous infection
(Image 5.2).
Postoperative instruction must highlight that the
patients should not bite, rub, or traumatize their
lips while under the effect of local anesthesia.
5.2 Sedation
A wide spectrum of sedation techniques is available for
use in dentistry. Regulations and guidelines might vary
among countries; and need to be followed according to
local authorities. Within the scientific literature, only few
authors describe the provision of dental care using seda-
tion in patients with EB. Examples of these are dental
extractions following intramuscular sedation in children
with dystrophic EB16 and adults with intermediate reces-
sive dystrophic EB (RDEB).17
Nitrous oxide inhalation sedation is an example of a
technique widely used in dentistry. In EB, it has been rated
as successful for pain control during dressing changes for
children at home.18 However, reports of its use for the den-
tal care of children with EB are lacking. If used, the skin
protection precautions described in this article should be
considered.
The recommendation based on the clinical experience
of the guideline development group is:
Moderate sedation should only be performed if all
the expertise and resources for emergency access
of a critical airway are available.
5.3 General anesthesia
Treatment under general anesthesia aids the provision of
extensive dental treatment and multiple extractions when
microstomia, vestibular obliteration, severity of soft tissue
fragility, and patients’ ability to cope with the procedure
are challenging.9,19 Nevertheless, the provision of dental
treatment under general anesthesia can remain challeng-
ing as severe tissue fragility can lead to intraoperative gen-
eralized mucosal sloughing secondary to minor trauma or
tissue manipulation, even if all precautions are taken.19–21
Microstomia will not improve under general anesthesia
and the surgeon will still be faced with limited oral access
even if nasal intubation, which is the intubation of choice,
is used. Access to the working area will remain a chal-
lenge (Image 5.3).4,22 Some authors recommend combined
IMAGE 5 . 3 Limited oral access due to microstomia during a
general anesthesia session using nasal intubation
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procedures using the same general anesthesia jointly with
other surgical specialities,23 eg, esophageal dilatation20
and bandage changes after hand surgery.4 The risk of tran-
sient bacteremia due to dental treatment should be dis-
cussed among surgical teams to decide whether it is pos-
sible to combine specific procedures.
When planning a procedure under general
anesthesia, the patient’s physician should be
consulted.1
The availability of an anesthetic team with expe-
rience in EB is preferred. If this is not available,
the use of local anesthesia or referral to a special-
ist center could be considered as alternatives.
5.4 Special considerations when
planning and performing dental treatment
under general anesthesia
Patients with EB, especially RDEB, often require multiple
surgical procedures within the oral cavity, gastrointestinal
tract, and on the hands. Among the main challenges for
the anesthetist are microstomia, ankyloglossia,24 perioral
scarring, limitedhead andneckmobility secondary to scars
and contractures, laryngeal stenosis, and esophageal stric-
tures. All of these challenges increase the risk of regur-
gitation and aspiration during anesthesia. In addition, as
an intraoperative complication, there is the risk of acute
airway obstruction due to oropharyngeal bulla develop-
ment while manipulating the airway.4 The best practice is
to work as part of a multidisciplinary group with derma-
tologists, surgeons, and nurses caring for patients with EB
under general anaesthesia.15
Skin protection
∙ Adhesives should be avoided if
possible.3,4,15,25–27 If silicone-based adhesives
are not available, minimally adherent products
and adhesive remover could be tried. Table 5.1
presents a variety of dressings available for
patients with EB.
∙ Preoperative preparation should includewound
care.28
∙ Skin areas that will be touched by the oral sur-
geon or anesthetist must be covered with non-
adherent dressings15,29–31 as skin sloughing eas-
ily occurs during patient handling (Image 5.4).3
Consideration should include any patient han-
dling including chin lifts during intubation.
∙ Some surgeons apply ointments or emollients
on their surgical gloves to avoid blistering the
IMAGE 5 . 4 Image taken during a sedation session: Skin areas
touched by the surgeons and in contact with nasal cannula are well
protected with soft silicone foam dressings. Lips are well lubricated
with an emollient
IMAGE 5 . 5 Patient transferring to operating table
skin,while other surgeons choose to apply these
lubricants on the skin and specific instruments
only. Examples of ointments, lubricants, and
emollients are described in Chapter 3.
Patient positioning and moving
∙ Stretchers and tables should be padded (eg, with
a wipeable foam, a wool blanket, seat cushion,
or mattress topper).15,20,22,25
∙ Patients should be allowed to place themselves
on the operating table (if possible) prior to
anaesthesia22,30 to avoid blister formation while
transferring (Image 5.5).
∙ Pressure points should be protected with
nonadherent or petrolatum-coated bandages,22
padding,28 or soft gauze30 (Image 5.6).
∙ Transfer and position changing should be done
by moving the blanket, not by sliding the
patient, as handling the patient could cause
damage.15,31 Slide sheets can be used as an aid.
∙ Patients should not be lifted under the arms, but
be lifted from under the buttocks and the back
of the neck.34
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TABLE 5 . 1 Protection dressings for the management of patients with epidermolysis bullosa
Contact layers Mepitel R© A
Mepitac R© A
Mepilex R© Transfer A
Silflex R© B
Adaptic Touch™ C
Siltape R© B
Bielastic silicone dressing Spycra R© Protect D
Bordered foam dressings Mepilex R© Border A
Mepilex R© Border LiteA
Biatain R© Silicone Lite E
Biatain R© Border Lite E
Allevyn Gentle Border F
Allevyn Lite F
KerraFoam™ G
UrgoTul Absorb Border H
Soft silicone mesh Mepitel R© A
Mepitel R© One A
Adaptic Touch™ C
Cuticell R© Contact I
Lipidocolloid dressings Urgotul R© H Restore R© J
Soft silicone foams Mepilex R© A
Mepilex R© Lite A
Mepilex R© Transfer A
Polymeric membrane PolyMem R© K
Soft silicone fixation tape Siltape R© B Mepitac R© A
Fixation bandages CoFlex R© Haft L
Soft-One R© M
Acti-Wrap N
Modified absorbent pads Telfa™ O
Restore R© J
Mesorb R© A
Adhesive removers Adapt™ Medical Adhesive Remover J
Appeel R© P
Niltac Adhesive Remover™ Q
Brava R© Adhesive Remover E
aThese examples of wound dressing brand names are only an aid to become familiar with themany available products as published by Pope and collaborators in the
2012 “A consensus approach to wound care in epidermolysis bullosa”32 and Denyer and collaborators in 2017 “International Consensus Best Practice Guidelines
for Skin and Wound Care in Epidermolysis Bullosa”.33 Updated information should be sought at DEBRA International Guidelines section.
AMölnlycke Health Care AB, Gothenburg, Sweden.
BAdvancis Medical, Nottingham, United Kindgom
CSystagenix Wound Management Ltd, Gatwick, UK
DReskin Medical NV, Tessenderlo, Belgium
EColoplast A/S, Humlebaek, Denmark
FSmith & Nephew PLC, London, UK
GCrawford Healthcare Ltd, Knutsford Cheshire, UK
HLaboratories URGO, Dijon, France
IBSN Medical GmbH, Hamburg, Germany
JHollister Incorporated, Libertyville, IL, USA
KFerris Mfg Corp, Fort Worth, TX, USA
LMilliken, Andover, MA, USA
MSnøgg, Vennesla, Norway
NActiva Healthcare Ltd, Burton upon Trent, UK
OCovidien, Dublin, Ireland
PCliniMed Limited, High Wycombe, UK
QConvaTec Inc, Flintshire, UK
IMAGE 5 . 6 Pressure point padding during general anesthesia
Eye protection
Ahigh incidence of perioperative corneal damage has been
observed; therefore, eye ointment and dressings should
always be used for protection.24 Once the patient is supine
under general anesthesia and before placing the drapes,
examine if there is proper eyelid closure. Lagophthalmos
(incomplete eyelid closure) is very common in patients
with EB due to eyelid skin scaring and may be worsened
by ectropion. Choice of eye lubrication will depend on the
patient’s eyelid occlusion and availability of specific mate-
rials. If the eyelids can be closed normally, the eyes should
be lubricated with an ophthalmic gel such as sodium
hyaluronate 2 mg/mL and draped with a nonadherent
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IMAGE 5 . 7 Eye protection with nonadherent dressing. All the
areas to be touched by the surgeon are protected with nonadherent
dressing
IMAGE 5 . 8 Eye protection in a patient with incomplete eyelid
closure: ophthalmic ointment is applied and covered with nonadher-
ent pads. Procedure is repeated every hour or as needed to maintain
eye moisture
dressing under the head drapes (Image 5.7). If silicone-
based bandages are not available, a softmoisture gauze can
be used.3,4,22,30 If there is lagophthalmos, the eyes need
to be thoroughly lubricated. This can be done by apply-
ing a petroleum-based ophthalmic ointment and main-
taining the eyes covered with nonadherent pads between
applications that should be done every hour (Image 5.8).
Upon recovery, patients should be informed about tran-
sient blurred vision due to the lubricant.33 If a patient
uses therapeutic bandage contact lenses, these should
not be removed. The eyes should be lubricated with any
preservative-free eye lubricant such as sodiumhyaluronate
1 mg/m: every 20 to 30 minutes and use the head dressing
as described above.35 Contact lenses for refractive purpose
should be removed before the procedure.
∙ Eyes need to be well lubricated throughout the
procedure as described above.3,4,22,24,30,31
IMAGE 5 . 9 Finger pulse oximeter probe secured with a non-
adhesive tape
IMAGE 5 . 1 0 Pulse oximeter on a toe covered with Mepitel R©
(Mölnlycke, Gothenburg, Sweden) to protect skin
Monitoring
Pulse Oximeter:
∙ If using a standard disposable finger/toe probe,
any adhesive part should be removed (cutoff)
and a specific nonadhesive tape3,31 or lubri-
cated gauze15,20 used to secure the pulse oxime-
ter sensor (Image 5.9). Clip-type pulse oxime-
try can be placed on the ear lobe.22,36 If a clip-
type pulse oximeter is used on a digit, the digit
can be wrapped with a contact layer (listed in
Table 5.1), petrolatum dressings, or commer-
cial plastic food wrap to avoid skin damage
(Image 5.10).33
Electrocardiogram (ECG)
∙ To secure the ECG leads, the adhesive parts
should be removed and the leads fixed using
a nonadhesive tape3,26 allowing only the lubri-
cated central portion to contact the patient’s
skin (Image 5.11).3,15,20,26,29
Noninvasive blood pressure:
∙ The cuff must be applied over an extremity that
is well wrapped with nonadherent material,31
bandages, or cotton4,15,20,22,30 (Image 5.12).
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IMAGE 5 . 1 1 ECG leads secured with nonadhesive dressings
IMAGE 5 . 1 2 Noninvasive blood pressure cuff applied on a pro-
tected leg
Capnography:
∙ If capnography needs securing/fixation, nonad-
hesive tape should be used (Table 5.1).
Tourniquet
∙ Avoid use of an elastic tourniquet or glove to
minimize skin trauma.33
∙ A tourniquet should be placed over a gauze
wrapped around the extremity or by minimal
manual pressure with lubricated hands, avoid-
ing shearing forces.15,30,33
∙ Avoid excessive rubbing during skin prepa-
ration using a “dabbing” motion for topical
antimicrobials.33
∙ The tourniquet should be released slowly and
carefully to avoid skin sloughing off.
Intravenous line securing
∙ Intravenous catheters can be secured with non-
adherent tape and then wrapped with gauze3,31
(Image 5.13). A foam dressing or petroleum-
coated gauze can be placed between the skin
and intravenous hub to avoid skin damage: it
should be securely wrapped with self-adherent
or nonadhesive elastic bandages around the
extremity, eg, Coban R© (3M, St. Paul, MN, USA)
IMAGE 5 . 1 3 Intravenous catheter secured with gauze
IMAGE 5 . 14 Fixing the electrosurgery pad with nonadhesive
technique
or Coflex R© (Andover Healthcare, Salisbury,
MA, USA).4,15,20,25,30 The wrist can be secured
using a foam-padded wrist support board.20
Instrument preparation
∙ Facemasks, endotracheal tubes, and nasal can-
nulas need to be well lubricated to reduce fric-
tion. This can be done with petrolatum,3,8,26,27
warm saline solution,22,36 or other appropriate
water-soluble emollients.
∙ If electrosurgery is planned, the adhesive bor-
der of the electrosurgery grounding pad (inac-
tive dispersive electrode) needs to be removed.
The pad can be fixed using a nonadhesive tape
allowing only the central portion to contact the
patient’s skin (Image 5.14).
Airway management
For safely maintaining an airway, further bullae and
erosions must be avoided.30 Nasal as well as oral intuba-
tion are reported in the literature.3,22,31 A nasal intubation
would be the first choice as it provides amore spacious sur-
gical field for dental treatment when compared to an oral
tube, and can also be securedmore easilywithout tape than
the oral tube.22
Both video-assisted laryngoscopy22 and fiberoptic
bronchoscopy3,15,27,28,31 have been successfully used to
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IMAGE 5 . 1 5 Fiber optic bronchoscopy in a patient with chal-
lenging intubation due to severe microstomia
aid intubation. Cases of intubation during spontaneous
ventilation with a fiberoptic bronchoscope have also
been reported.4 Minimal chin lift and head tilt should
be exerted and gentle manipulation of the head with a
hand below the occiput and the jaw must be considered.36
Slow and gentle manipulation reduces tissue damage
(Image 5.15).
∙ Nasal intubation is the first choice.22
∙ Specific recommendations to aid intubation
include: a smaller sized laryngoscope26 and a
small size cuffed endotracheal tube.31
∙ Nonadhesive tape should be used to secure the
endotracheal tube (Table 5.1, Image 5.3).22
∙ A throat pack (oropharyngeal pack) must be
placed for any dental procedure.3,26,31,36 The
throat pack should be lubricated with water
soluble lubricants, as, for example, Surgilube R©
(Fougera, Melville, NY, USA) to reduce the risk
of it adhering to the mucosa. If lubricants are
not available, the throat pack could be soaked
with water to reduce the risk of adherence.
Surgical site
∙ The surgical site should not be scrubbed. Dis-
infection solutions should be poured, gently
dabbed, or sprayed on the skin.4,15
∙ All perioral tissues and commissures should
be well lubricated.3,31 Lubrication can be done
with petrolatum or any other ointment or emol-
lient (Images 5.4, 3.21 [in Chapter 3], and 4.6 [in
Chapter 4]).
∙ Suction: Bullae formation or epithelial slough-
ing can occur upon contact with the suction
tip.20 If possible, the suction tip should be
leaned on hard tissue, ie, on tooth or bone sur-
face (Image 5.16).24 Vacuum suction can cause
extensivemucosal sloughing, its use needs to be
very gentle (Image 5.17).
IMAGE 5 . 1 6 Suction tip leaned on tooth surface to prevent
mucosal sloughing
IMAGE 5 . 17 Mucosal sloughing after extensive dental surgery
Patient discharge
The time of discharge after dental surgery varies. While
some reports in the literature noted discharge on the same
day as the surgery,36 otherswaited 24 hours postoperatively
and some even 3 days postprocedure.22,26,28 The time to dis-
charge will depend on the extent of the surgery and the
potential benefits of keeping the patient in hospital will
need to be weighed against the risks of hospital-acquired
infections.
Complications
In order to have a well-informed risk/benefit discus-
sion with the patient and their family, it is important to
know the complications reported in the literature on gen-
eral anesthesia in patients with EB. In a review of 121
surgical procedures, no death or other major perioper-
ative anesthetic complication occurred.15 Another series
of 344 surgical procedures under general anesthesia at a
reference center for EB reported the following complica-
tions related to anesthesia: postoperative nausea/vomiting:
8 (2.3%), new bullae: 7 (2.0%), regurgitation: 2 (0.6%),
and corneal ulcers: 1 (0.3%).30 Other studies describe the
development of new blisters as the most common post-
operative complication.3,15 Significant injury after poor
soft tissue handling can occur when inexperienced mem-
bers of the team are not aware of the risks of handling
patients with EB, eg, inadvertent taping of the eyelids.30
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Maxillary alveolar process fracture secondary to laryn-
goscopy was reported in a patient with severe general-
izedRDEBwith poor bone health, severemicrostomia, and
prominent upper incisors.37
As to the intraoral mucosa, generalized sloughing sec-
ondary to minor trauma or tissue manipulation can occur
even if all precautions are taken. Patients with severe
fragility will still develop intraoperative mucosal slough-
ing secondary to retraction andminor trauma of the proce-
dure itself19–21 (Image 5.17). During the postoperative heal-
ing period, patients might experience their lips sticking
together if both lips have substantial damage. Therefore,
patients should be advised to continuously lubricate their
lips and corners of the mouth with lubricants, petrola-
tumor other emollients, for example, Vaseline R© (Unilever,
USA), Linovera R© (B.Braun), or other emollients available
locally. Performing mouth opening, lip, and tongue move-
ment exercises is also important tomaintain oral functions.
Images. We would like to acknowledge the support of
patients, clinicians, and researchers from different clinical
centers globally for collaborating by providing images for
the present guideline. Written informed consent has been
obtained for all images where patients can be recognized.
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